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1. INTRODUCTION 
Actin dynamics is essential for a variety of cellular processes, namely in supporting shape, 
division and motility of the cell, intracellular transport and cell signaling. The actin 
cytoskeleton shows a remarkable evolutionary conservation, from single cell organisms to 
highly complex mammals. Moreover, actin dynamics is a tightly regulated process, wherein 
the proteins of the family of Rho GTPases are the main players in controlling actin turnover. 
Considering its essential role in a variety of cellular activities, it is not surprising that the actin 
cytoskeleton is a prime target of an array of pathogens. Pathogenic bacteria have evolved to 
usurp actin either to pursue an intracellular lifestyle or to remain unperceived by the immune 
system of the host. In the present work, I address modulation of actin regulators by enteric 
pathogens during the course of infection.  
Infectious diseases remain the major problem in developed and developing countries. 
Remarkably, although enteric bacteria target the same host, their disease causing mechanisms 
are distinct. For example, enteropathogenic and enterohemorrhagic Escherichia coli (EPEC 
and EHEC) adhere closely to the host cell plasma membrane, eliminate the enterocyte 
microvilli and induce cytoskeletal rearrangement resulting in the formation of pedestals 
beneath adherent bacteria (Lommel et al., 2004). Both EPEC and EHEC largely remain 
extracellular in the lumen of the gut (Wong et al., 2011). For intracellular bacteria, the main 
point is to get access to the intracellular space of the host cells. In particular, Salmonella spp. 
and Shigella spp. invade eukaryotic target cells by activating Rho GTPase signaling 
pathways, and internalize in beneficial replicative niches within the host. In this study, I focus 
mainly on Salmonella pathogenesis. 
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1.1 Rho GTPases 
Rho GTPases are main actin regulators. Together with Ras, Rab, Arf and Ran they belong to 
the Ras- superfamily that comprises approximately of 150 members in humans (Vigil et al., 
2010).Remarkably, all Rho proteins share a common G-domain (GDP/GTP-binding domain) 
and an isoprenylated moiety on the C-terminal region, which is essential for their membrane 
localization and for their association with guanine nucleotide dissociation inhibitor (GDI). 
Like other small GTPases, Rho proteins act as molecular switches that cycle between active 
GTP and inactive GDP forms. The activity of Rho GTPases is tightly coordinated by more 
than 85 guanine nucleotide exchange factors (GEFs), 60 GTPase-activating proteins (GAPs) 
and at least 3 GDIs (Jaffe & Hall., 2005;Cherfils & Zeghouf 2013). Indeed, GEFs promote the 
exchange of GDP to GTP, whereas GAPs catalyze the hydrolysis reaction of GTP to GDP+Pi, 
and GDIs prevent activation and degradation of Rho proteins in the cytosol (Figure 1) 
(Cherfils & Zeghouf 2013; Jaffe & Hall., 2005).  
 
Figure 1: Regulation of the Rho GTPases cycle by GEFs, GAPs, and GDIs.The active conformation of Rho-family 
GTPases is characterized by hydrolysis of GDP to GTP, a process induced by GEFs. At the same time, Rho proteins are 
inactivated by certain GAPs. GDIs bind the Rho-GDP form and keep the protein in its inactive conformation in the cytosol 
(Aktories & Barbieri., 2005). 
Members of the Rho GEF family, also known as Dbl family, commonly contain a Dbl-
homology (DH) domain, encoding the catalytic activity, and a pleckstrin homology (PH) 
domain, which mediates membrane localization of these regulators (Bishop & Hall., 2000). 
Activation of Rho GTPases is mediated by binding of the DH domain of GEFs, resulting in 
the release of GDP and spontaneous binding of GTP (van Buul et al., 2014). 
The most studied GTP-binding proteins of the Rho family are RhoA, Rac1 and Cdc42, which 
are all involved in regulation of the actin cytoskeleton. RhoA is a 22 kDa-protein which is 
involved in organizing contractile actin/myosin stress fibers and focal adhesions (Ridley & 
Hall., 1992). Rac1 is a 21 kDa-protein essential for the formation of focal complexes and 
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sheet-like leading edge protrusions, referred to as lamellipodia (Ridley et al., 1992). Cdc42 is 
known to induce the formation of filopodia or microspikes and to be important for cell 
polarity.  
Rho GTPases are involved in many cellular functions such as cell polarity, cell cycle 
progression, apoptosis, transformation, microtubule dynamics, vesicular transport pathways 
and gene transcription, as well as a variety of enzymatic activities, to name only some. 
Regulation of the actin cytoskeleton during infection is another important function, which is 
not a surprise (Aktories & Barbiere., 2005; Heasman & Ridley, 2008; Etienne-Manneville & 
Hall, 2002; Lemichez & Aktories, 2013).  
Due to these diverse cellular functions, host GTPases are preferred molecular targets for 
bacterial effector proteins that mimic eukaryotic regulators of the GTPases cycle (Boquet, 
2000). Thereby, intracellular bacterial pathogens induce extensive changes in host signaling 
pathways allowing them, for instance to invade epithelial cells and establish the intracellular 
niche for further replication. Salmonella effectors proteins, including SopE, SopE2, SptP, 
SopB, SipC and SipA, are involved in the entrance of this pathogen into non-phagocytic cells. 
Functions of these virulence factors in the pathogenesis of Salmonella are described in more 
detail below. 
 
1.2 Microtubule assembly, organization and dynamics 
Together with actin (microfilaments), septins and intermediate filaments, microtubules 
participate in the maintenance of the cellular architecture. Microtubules are built as cylindrical 
filaments assembled as head-to-tail polymerized α- and ß- tubulin heterodimer subunits. The 
γ-tubulin acts as a basis for microtubule nucleation. A microtubule is a hollow tube with a 
diameter of 24 nm and consists of 13 protofilaments that are built from dimers of α- and ß- 
tubulin (Figure 2 A). Microtubules originate from γ-tubulin in the microtubule organizing 
center (MTOC) which forms around the centrosome (Fig. 2 C). Dynamic instability of these 
cytoskeleton polymers is characterized by a continuous process of polymerizing (growth) and 
depolymeriziting (shrinkage) of the microtubules on the faster-growing ends (plus end). 
Transition from growth to shrinkage is known as ‘catastrophe’ and the reverse process is 
termed ‘rescue’ (Figure 2 B) (Horio & Hotani, 1986; Walker et al., 1988). Polymerization of 
microtubules is a GTP-dependent process, in which both α- tubulin and ß- tubulin must be 
bound to GTP (Akhanova & Steinmetz, 2015; Wade, 2009). New αß-dimers are added to a 
Introduction 
4 
 
microtubule followed by hydrolysis of the GDP to GTP. The depolymerization phase is 
characterized by a rapid loss of GDP-tubulins from the protofilaments leading to rapid 
disassembly (Figure 2 B) (Desai & Mitchison, 1997; Conde & Caceres, 2009).  
Motorproteins of the kinesin family transport various cargoes from the minus to plus end (i.e. 
from cell center to the periphery). At the same time, dyneins move cargo to the minus end 
towards the cell center. Thereby, these molecular motors facilitate intracellular transport along 
microtubules. 
 
(A) Assembly of polar microtubules. (B) Microtubule dynamic instability (Conde & Caceres, 2009). (C) The structure of the 
centrosome that serves as the main MTOC (Wikimedia, https://commons.wikimedia.org). 
Intracellular pathogens exploit the microtubule network and molecular motors, associated 
with it, in order to acquire nutrients coming from different host compartments. Indeed, 
Salmonella manipulates this molecular assembly for the establishment and the stability of the 
bacterial replicative niche (also compare below Figure 7). 
c 
Figure 2: Microtubules and centrosome.  
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1.3 Salmonella 
Salmonella is a rod-shaped Gram-negative facultative intracellular pathogen, whose cells 
range from 0.7 to 1.5 µm in diameter and from 2 to 5 µm in length (Figure 3). The genus 
Salmonella is comprised of two species, Salmonella bongori and Salmonella enterica, which 
are in turn classified into six subspecies: enterica, salamae, arizonae, diarizonae, houtenae, 
and indica (de Jong et al., 2012). To date, more than 2500 serovars of Salmonellaenterica are 
known; however, I will be focussing on Salmonella enterica serovar Typhimurium in this 
thesis. Infection with non-typhoidal Salmonella (NTS), in particular Salmonella enterica 
serovar Typhimurium, is usually characterized by self-limiting diarrhea, with symptoms 
disappearing within 2-5 days. Infection with Salmonella Typhi results in the development of 
systemic infection, which manifests itself as typhoid fever and often leads to death of the 
patient. 
 
Figure 3: Salmonella (red) invades a host cell (blue) by induction of membrane ruffling. Image courtesy of Manfred 
Rohde (HZI). 
Pathogenic Salmonella spreads through fecal contamination of food and water. Poultry, meat, 
dairy products, eggs are common sources of Salmonella infection. It is well known that the 
stomach has an acidic milieu (pH 2), and most of intracellular pathogens are unable to survive 
in such hostile environment; however, Salmonella is an exception. Due its adaptive acid 
tolerance, salmonellae are capable to survive in such harsh acidic condition within a host 
(Garcia-del-Portillo et al., 1993; Reisenberg-Wilmes et al., 1996). Salmonella overcomes 
multiple defense mechanisms of the small intestine in order to reach and attach to the 
intestinal epithelium, thus initiating infection. 
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1.4 Epidemiological situation of non-typhoidal Salmonellosis in EU/EEA countries 
The European Centre for Disease Prevention and Control (ECDC) surveillance of food and 
waterborne diseases and zoonosis has rated Salmonella as the most frequently reported 
pathogen in foodborne outbreaks (for example 1 533 Salmonella outbreaks have been 
estimated in 2012) and the second most commonly reported enteric infection in the European 
Union/ European Economic Area (EU/EEA). The surveillance report indicates a 10% 
reduction in the number of cases of non-typhoidal salmonellosis from 2010 to 2012 (102 456 
reported cases in 2010 to 92 443 cases in 2012). Total numbers of disease are quite different 
among EU/EEA countries: the highest notification rates have been documented in the Czech 
Republic and Slovakia (>70 cases per 100 000), followed by Hungary and Lithuania (>55 
cases per 100 000), while the lowest rates have been reported in Portugal (<2 cases per 
100 000) (Niskanen et al., 2015). 
 
Figure 4: Trend in the number of confirmed non-typhoidal salmonellosis cases in Germany. Data were obtained from 
ECDCs surveillance, 2008-2012 (Niskanen et al., 2015). 
The highest prevalence of salmonellosis has been reported in children between 1 and 4 years 
of age (>90 cases per 100 000), and the lowest in the age group 25-44 years (<12 cases per 
100 000), for both males and females. Disease caused by Salmonella typhimurium has a 
strong seasonal pattern with the highest peak in the summertime and a second smaller peak in 
January (Niskanen et al., 2015). 
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1.5 Assembly of the bacterialT3SS 
Like many other Gram-negative bacterial pathogens, Salmonella, as well as EPEC and 
EHEC,utilizes a needle-like type three secretion system (T3SS), also known as injectisome, to 
secret an arsenal of virulence factors into the host cytoplasm. The injectisome is built of 
approximately 25 proteins embodying a fascinating molecular machine composed of a basal 
body, and an extracellular needle that emerges from the outer membrane. Despite the fact that 
there are seven different families of injectisomes, the structure of the needle complex is 
universal among species (Cornelis, 2006). The basal body of T3SS comprises of two rings 
embedded into the inner and the outer bacterial membrane. The inner membrane (IM) ring 
contains 24 subunits of SctJ and SctD (united secretion and cellular translocation (Sct) names) 
(Prgk and PrgH in Salmonella) (Moest & Meresse, 2013). The outer membrane (OM) ring is 
composed of 12-15 copies of secretin protein SctC (Salmonella’s InvG) (Schraidt & 
Marlovits, 2011). The extracellular hollow needle of approximately 60-80 nm in length 
functions as a sensory probe to detect a host cell and to secrete virulence effector proteins that 
promote bacterial infection. The needle is associated with the basal body of T3SS via the 
inner rod protein SctI (Salmonella’s PrgJ) (Marlovits et al., 2004). An ATPase plays a key 
role in the release of bacterial effectors from chaperones and their secretion (SctN) 
(Salmonella’s InvC) (Akeda & Galan, 2005). Finally, translocation of bacterial virulence 
effectors is facilitated by the translocon, a protein complex that forms a pore in the host cell 
membrane (Cornelis, 2006; Burkinshaw & Strynadka, 2014) (Figure 5).  
 
Figure 5: Organization of the injectisome and its components. Cryo-electromicroscopic data of a 3D surface 
representation of the needle complexes (left panel side view, middle panel cut view). The T3SS and its elements are 
schematically depicted (right panel). Cytoplasmic components are colored in yellow, export apparatus components in red, 
base and needle components in blue, and needle tip and translocator proteins in green (Diepold & Wagner, 2014). 
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Abbreviations: IM, inner membrane; OM, outer membrane; MS, membrane and supramembrane; Sct, secretion and cellular 
translocation (united Sct names). 
It should also be pointed out that the fully assembled T3SS is activated only upon host cell 
contact. Using time-lapse microscopy, Hardt and colleagues demonstrated that Salmonella 
secretes the effector protein SipA into an eukaryotic cell within 10-90 seconds following 
direct contact with the host, and that the entire injection process proceeds for 100-600 seconds 
(Schlumberger et al. 2005). 
There is no doubt that the utilization of a complex molecular machinery such as T3SS and 
secretion of bacterial virulence effectors plays a pivotal role in the pathogenicity of Gram-
negative bacteria. 
 
1.6 Salmonella invasion 
For the successful infection, Salmonella utilizes two type 3 secretion systems (T3SSs) 
encoded within Salmonella pathogenicity islands-1 and -2 (SPI-1 and SPI-2) during 
pathogenesis. Through the action of SPI-1 T3SS effectors are translocated across the plasma 
membrane of host cell, enabling Salmonella to invade non-phagocytic cells, through re-
arrangement and polymerization of actin and resulting in membrane ruffling. Manipulation of 
the host’s actin cytoskeleton is achieved by activation of several T3SS-1 translocated 
effectors such as Salmonella invasion proteins (Sips) and Salmonella outer proteins (Sops) 
(Donnenberg, 2000; Schlumberger & Hardt, 2006). While SipA and SipC directly bind to 
actin and are involved in actin polymerization and bundling, SopE, SopE2 and SopB 
indirectly activate host actin remodeling by triggering Rho-GTPases. SopE functions as GEF 
for Cdc42 and Rac1, SopE2 targets Cdc42, and SopB activates host GTPases indirectly by 
manipulating the host phosphatidyl-inositol-phosphate metabolism (Hänisch et al., 2011; 
MgGhie et al., 2009; Friebel et al., 2001; Hardt et al., 1998; Agbor & McCormick, 2011). 
Later, upon completion of invasion, these small GTPases are downregulated by the GAP 
activity of T3SS effector SptP (Figure 6 A) (Rottner et al., 2005; Orchard & Alto, 2012; Fu & 
Galan, 1999; Hardt et al., 1998). Additionally an important feature of SptP is the ability to 
function as tyrosine phosphatase (Humphreys et al., 2009). 
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Figure 6: Salmonella manipulates host cell behavior to its benefit. A. Salmonella induces host cell invasion by delivering 
T3SS-1 bacterial virulence effectors into eukaryotic cells.  While T3SS-1 effectors, SopE and SopE2, mimic eukaryotic GEF 
by triggering Rac1 and Cdc42, another effector, SptP, functions as GAP and downregulates the activity of these Rho GTPase. 
SipA and SipC directly interact with actin and stabilize F-actin. B. Salmonella resides in the intracellular niche, the so-called 
SCV, and translocates T3SS-2 effectors. SifA interacts with host protein SKIP and RhoA GTPase. SseF and SseG associate 
with microtubules. The function of SifB is not well defined (Rottner et al., 2005). 
 
1.7 The Salmonella-Containing Vacuole 
The host environment is rich in organic nutrients and serves a habitat for intracellular bacteria. 
Upon cell invasion, Salmonella resides in the so called Salmonella-containing vacuole (SCV). 
This unique compartment matures from the initial phagosome and contains early endosomal 
markers, such as early endosomal antigen 1 (EEA1), Rab5 and transferrin receptors. The latter 
is substituted within 20–40 min by late endosome/lysosome markers (LE/Lys), such as 
vacuolar ATPase (vATPase), lysosome-associated membrane proteins (LAMPs) and the 
lysosomal hydrolases such as cathepsins (Steele-Mortimer, 2008). Movement of SCVs from 
the site of bacterial internalization to the perinuclear region within 5 µm of the microtubule-
organizing centre (MTOC) is controlled by the late endosomal GTPase Rab7 and its effector, 
Rab-interacting lysosomal protein (RILP) (Ramsden et al., 2007; Harrison et al., 2004). 
After 2-4 hours post invasion, pathogenic bacteria employ SPI-2 T3SS effectors to mature the 
SCV and establish a niche for survival and replication within host cells (Hensel et al., 1995; 
Ruiz-Albert et al., 2002). A subset of T3SS-2 effectors, including SifA, PipB2, SopD2, SseG 
and SseF, is required for the formation of Salmonella-induced filaments (SIFs) (also see 
below section 1.8). At the same time, SseJ and SpvB down-regulate the appearance of highly 
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dynamic tubules from SCV (Ruiz-Albert et al., 2002; Figueira &Holden, 2012). Furthermore, 
SifA binds to the host protein SKIP (SifA and kinesin-interacting protein), an interactor of the 
endosomal GTPase Rab9 (Figure 6 B) (Diacovich et al., 2009; Jackson et al., 2008; Ohlson et 
al., 2008; Zhao et al., 2015). While SifA preferentially interacts with GDP-bound RhoA, SseJ 
binds to GTP-bound RhoA. Recent evidence suggests that the synergistic action of two T3SS-
2 effectors, SifA and SseJ, along with host SKIP and RhoA to promote endosomal tubulation 
(Ohlson et al., 2008). Other virulence factors, namely SseF and SseG, that are also 
translocated by the SPI2-encoded T3SS, associate with microtubules and are engaged in 
alterations of the architecture of the microtubule network, including forcing of massive 
bundles close to SCV and tubular endosomal aggregates (Figure 6 B) (Kuhle et al., 2004; 
Abrahams et al., 2006). Much less is known about the biological function of the T3SS-2 
effector protein SifB in Salmonella pathogenesis. BLAST database analyses of SifA and SifB 
bacterial effectors recognized 30% sequence similarity over the length of these proteins, thus 
SifB was named after its analog to SifA (Miao & Miller, 2000). However, infection 
experiments with bacteria lacking SifB demonstrate a phenotype similar to that of 
Salmonella-WT, at least in vitro (Rajashekar et al., 2014; Ruiz-Albert et. al., 2002). Detailed 
analysis of the role of SPI2 in vivo demonstrate that Salmonella strains harboring mutations in 
SPI-2 virulence genes are able to invade cells and reach host organs, but are attenuated in 
intracellular replication (Shea et al., 1999; Cirillo et al., 1998; Hensel, 2000). 
 
1.8 SIFs, a dynamic tubular network induced by Salmonella 
Pathogenic Salmonella induces a tubular network formation of the so called Salmonella-
induced filaments (SIFs). These are characterized by the presence of a defined set of proteins, 
namely sorting nexins (SNX), Salmonella-induced secretory carrier membrane protein 3 
(SCAMP3), and lysosome-associated membrane protein 1 (LAMP1). At different time points 
of infection some of these markers may be absent, defining specific subsets and stages of SIF 
formation (Figure 7) (Malik-Kale et al., 2011; Schroeder at al., 2011). Furthermore, 
Salmonella-induced tubules are formed along microtubules that serve as cytoskeletal scaffold 
for them. Previous publications report that (Brumell et al., 2002), inhibition of microtubules 
with nocadozole results in disruption of these tubulated membranes. Characteristic features 
and the mechanism of formation of early and late tubules are described in more detail below. 
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Figure 7: Salmonella-induced tubular networks. After its internalization, Salmonella (green rod) resides in SCV that is 
enriched in SNX1 and SNX3. At 10 min post invasion (p.i.) SVATs are formed by SNX1, at 30 min p.i. SNX3 tubules 
appear. The T3SS-1 effector SopB mediates the accumulation of the phosphoinositide [PI (3) P], followed by the recruitment 
of SNX1 and SNX3 on the vacuolar membrane. After 2 hours p.i. mature SCV moves to its replication niche, close to the 
MTOC. Then late T3SS-2 dependent tubular networks (SIFs, SISTs, and LNTs) are assembled (Schroeder at al., 2011). 
Abbreviations: MTOC, microtubule-organizing center; LAMPs, lysosome-associated membrane proteins; LNTs , LAMP1-
negative tubules; SCV, Salmonella –containing vacuole; SNX, sorting nexin tubules; SIF, Salmonella-induced filaments; 
SISTs, Salmonella-induced secretory carrier membrane protein 3 (SCAMP3) tubules; SVATs, spacious vacuole-associated 
tubules; TGN, trans-Golgi network. 
 
1.8.1 The early T3SS-1 dependent SNX tubules 
Within the first hour post invasion, Salmonella develops sorting nexin (SNX) tubules, 
depending on the T3SS-1 bacterial effector SopB (Figure 1.7) (Bujny et al., 2008; Braun et 
al., 2010). Among the 30 proteins of the SNX family, SNX1 and SNX3 localize to the early 
SCV already after 10 min p.i., before they reach the cell center at 30-60 min p. i. SNX1 forms 
extensive highly dynamic spacious vacuole-associated tubules (SVATs) with peaks at 10-15 
min post invasion, with a subsequent decrease in vacuole size (Bujny et al., 2008). SNX3 
tubules appear at 30 min and disappear 2 hours after the invasion (Braun et al., 2010). The 
Bin-amphiphysin-Rvs (BAR) domain of SNX1 facilitates sensing of membrane curvature and 
induces tubulation (Van Weering et al., 2010; Cullen, 2008).  
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1.8.2 The late T3SS-2 dependent tubular networks: SIFs, SISTs and LNTs 
1.8.2.1 SIFs 
In 1993 Garcia-del Portillo and colleagues were the first to identify the appearance of 
extensive highly dynamic filaments, with collapse velocities of 0.4-0.5 µm x sec
-1 
during 
Salmonella infection. These compartments have been termed Salmonella-induced filaments 
(SIF) (Garcia-del Portillo et al., 1993; Krieger et al., 2014; Liss & Hensel, 2015). Activation 
of SPI-2 T3SS-translocated effectors is required for the induction of SIF which harbors late 
endosomal markers including lysosome-associated membrane protein 1(LAMP1), vacuolar 
vATPase (vATPase), endosome-associated GTPase Rab7 (Steele-Mortimer, 2008; Drecktrah 
et al., 2008; Garcia-del Portillo et al., 1993; Rajashekar & Hensel, 2011). Numerous studies 
have documented that after 3-4 h p.i. the formation of tubular endosomal aggregations occurs 
from the special vacuolar compartment, known as the Salmonella-containing vacuole. The 
late phase of Salmonella infection (8 h p.i.) is characterized by stabilization of an extensive 
tubular endosomal network (Drecktrah et al., 2008; Rajashekar et al., 2008). Dynamic 
behavior and morphologic variation of SIFs were extensively studied in the last years. Recent 
work by the group of Michael Hensel reported that infection with various mutant Salmonella 
strains defective in one of the effector proteins of the SPI2-T3SS leads to intracellular 
phenotypic differences. In contrast to wild-type Salmonella which induces the highly dynamic 
SIF of 160-200 nm in diameter, a pathogen defective in PipB2 effector induces bulky (with 
diameters of more than 500nm) non-dynamic SIFs, whereas the SseF- or SseG- mutant strains 
induce thin (with diameters of less than 100 nm) dynamic SIFs. The most dramatic 
phenotype, which is characterized by the entire absence of tubular membrane compartments, 
was observed in cells infected with a mutant strain deficient in SifA (Rajashekar et al., 2014; 
Brumell et al., 2001). 
 
1.8.2.2 SISTs 
The members of the secretory carrier-associated membrane protein (SCAMP) family 
associate with the trans-Golgi network (TGN) and participate in protein trafficking along 
endosomal pathways. Salmonella-induced SCAMP3 positive tubules (SISTs) are not only 
characterized by the presence of SCAMP3 but also by the absence of late endosomal proteins, 
including LAMP1. Similar to SIF formation, SCAMP3 tubulation depends on the T3SS-2 
effectors PipB2, SifA, SopD2, SseF and SseG (Haraga et al., 2008; Mota et al., 2009). The 
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molecular mechanism of SISTs forming likely involves formation of a PipB2-kinesin-1 
complex, followed by a centrifugal extension of SCAMP3 tubules (Mota et al., 2009). 
 
1.8.2.3 LNTs 
Finally, LAMP1 negative tubules (LNTs) act as precursors of SIFs and SISTs, thereby 
contributing to the recruitment of endocytic vesicles and to the membrane stability of SCVs. 
While the T3SS-2 effector SifA activates the formation of LNTs, the bacterial virulence 
protein SopD2 inhibits this process. Similar to SIFs, LNTs contain vATPase and cholestrerol, 
but they lack LAMP1 and Rab7 (Schroeder et al., 2010). 
 
Remarkably, the T3SS-1 effector PipB2 interacts with kinesin light chain and regulates 
centrifugal extensions of SIFs, SISTs, and LNTs (Henry et al., 2006; Knodler & Steele-
Mortimer, 2005; Mota et al., 2009; Schroeder et al., 2010). It has been suggested that the 
formation of early SNX tubules is essential for SCV maturation and its movement towards the 
MTOC (Bujny et al., 2008; Braun et al., 2010). SIFs, SISTs, and LNTs are important during 
the late stages of the intracellular lifestyle of Salmonella. The molecular mechanism of the 
formation of tubular networks as induced by Salmonella, and exact physiological functions of 
these tubules remain unclear. 
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1.9 Elimination and survival of Salmonella as a result of autophagy 
Autophagy is derived from the Greek words “auto” (“self”) and “phagein” (“to eat”). 
Autophagy is involved in the delivery of cytoplasmic material that is destined for degradation 
into lysosomes. This intracellular process is characterized by the formation of a double-
membrane vesicle called autophagosome and the involvement of 36 autophagy-related (ATG) 
proteins. Beside its primary function, autophagy is tightly associated with the host immune 
defense mechanism against intracellular pathogens.  
 
1.9.1 Autophagy of cytosolic bacteria 
Recent studies highlight that Salmonellaenterica serovar Typhimurium can also survive in the 
cytosol of epithelial cells (Knodler et al., 2014; Malik-Kale et al., 2012). Interestingly, these 
cytosolic bacteria become ubiquitinated and can simply be recognized by autophagic 
adaptors, such as p62, nuclear dot protein (NDP52) and optineurin (OPTN) which belong to 
sequestosome 1/p62-like receptors (SLRs) family. These SLRs modify membranes for 
autophagosome formation through their interaction with an autophagosomal membrane-
anchored member of the ATG8 family (LC3), resulting in degradation of intracellular bacteria 
(Figure 8, pathway 1) (Deretic, 2012). 
 
1.9.2 Autophagy of bacteria in SCV 
As mentioned earlier, Salmonella uses T3SS-1 to invade host cell by forming pores of ~3.5 
nm in diameter in the host cell membrane (Knodler, 2015). Meanwhile, cytosolic galectins, 
particularly galectin 8, serve as danger receptors and accumulate on the damaged vacuole in 
order to protect host cells against penetration of pathogens. Galectin 8 triggers NDP-52 and 
LC3 accumulation to the defective SCV, thereby inducing antibacterial autophagy and 
elimination of cytoplasmic pathogens (Figure 8, pathway 2) (Thurston et al., 2012; 
Birmingham et al., 2006). 
The work by the group of Prof. Dr. Wolf-Dietrich Hardt demonstrate that non-canonical 
autophagy is involved in repairing SCV membrane damaged by T3SS-1. Authors have 
identified that the sealing of endosomal membranes damaged by T3SS-1 effectors 
unexpectedly requires autophagy regulators (mTOR), recruitment factors (galectins, OPTN), 
initiation factors (ULK1, PI-3 kinase C3, Beclin1, ATG2A, and ATG9), ATG12- (ATG5, 
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ATG7, ATG12, and ATG16L1) and ATG8- conjugated systems, as well as regulators of SCV 
maturation (GTPases Rab5 and Rab7). Subsequently, it promotes bacterial maturation and 
replication by induction of T3SS-2 effectors. (Figure 8, pathway 3) (Kreibich et al., 2015). 
Nevertheless, the exact molecular mechanism of repairing the ruptured SCV remains poorly 
understood. 
Recent findings shed light on different roles of the autophagy machinery during infection. 
Many questions remain open, for instance, it is unclear how the decision is made whether the 
autophagy machinery of the host that recognizes the damaged SCV membrane would either 
lead to degradation or to recovery. 
 
Figure 8: Autophagy targets Salmonella. After bacterial entry, Salmonella resides in a membrane bound compartment 
called the Salmonella-containing vacuole (SCV), docking early (Rab5, EEA1) and late (Rab7, Rab9, vATPase and LAMP1) 
endosomal markers. To invade a host cell, Salmonella secretes T3SS-1 effectors that form a pore in the host cell membrane 
which allow some bacteria to escape from the vacuole and enter the cytosol. (1) Antibacterial autophagy. Cytosolic 
salmonellae are ubiquitinated and became recognized by autophagy adapters including p62, nuclear dot protein (NDP52), and 
optineurin (OPTN). These adapters interact with LC3 to promote lysosomal killing of cytosolic bacteria. (2) Autophagy 
recognizes intracellular Salmonella in damaged vacuoles. In this case, carbohydrate modifications within the ruptured SCV 
are sensed by galectins, NDP-52, and recruit ubiquitin to the membrane, which subsequently activates the autophagy pathway 
leading to bacterial degradation. (3) Autophagic machinery repairs the damage of SCV mediated by T3SS-1 effectors. In 
contrast to antibacterial autophagy, Salmonella can manipulate the host autophagic system for its own benefit and to cause 
disease. SCV is saturated with autophagosome marker LC3 leading to the activation of the phagosomal repair pathway, 
followed by translocation of T3SS-2 effectors for SCV maturation process and SIF formation (Owen & Casanova, 2015).
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1.10 WxxxE family 
Work by the Alto group classify the WxxxE protein family composing of 24 bacterial effector 
proteins, including Map, EspM and EspT of EHEC/EPEC and the related Citrobacter 
rodentium, IpgB1 and IpgB2 of Shigella spp., and SifA and SifB of Salmonella spp. These 
distinct effectors harbor a common Trp-xxx-Glu (WxxxE) motif, comprising two invariant 
amino acids, tryptophan (W) and glutamic acid (E) (Alto et al., 2006). The best characterized 
member of this family is the T3SS effector protein Map that functions similar to a eukaryotic 
GEF for Cdc42, inducing the formation of filopodia during early stages of infection (Huang et 
al., 2009). Another WxxxE effector of the attaching and effacing (A/E) pathogen group, 
EspT, triggers cellular GTPases Rac and Cdc42, thereby inducing actin cytoskeleton 
rearrangements followed by the formation of membrane ruffles and lamellipodia (Raymond et 
al., 2011; Bulgin et al., 2009). The Shigella WxxxE effector IpgB1 induces the formation of 
membrane ruffles via activation of the Rho GTPase Rac1 and Cdc42, thereby facilitating 
Shigella invasion (Ohya et al., 2005). Furthermore, IpgB1 was reported to function as a 
bacterial GEF for Rac1 and Cdc42 (Huang et al., 2009). At the same time, IpgB2 stimulates 
formation of stress fibers by mimicking eukaryotic GEF-activity for RhoA (Klink et al., 
2010). 
The Salmonella WxxxE effector SifA comprises two domains. Via the N-terminal region, it 
binds to the C-terminal pleckstrin homology (PH) domain of a host protein SKIP (SifA and 
kinesin-interacting protein), whereas the C-terminal region of SifA consists of a canonical 
WxxxE-domain (Figure 9) (Diacovich et al., 2009; Jackson et al., 2008; Ohlson et al., 2008). 
This fold is highly similar to that of the Salmonella TTSS-1 effector SopE (Figure 9) 
(Buchwald et al., 2002).  
 
 
Figure 9: Structural comparison of MAP, SifA, and 
SopE. Superimposition of MAP (violet), SifA (gold) 
and SopE (turquoise). MAP, canonical bacterial GEF of 
the WxxxW family, targets Cdc42. The C-terminal 
region of SifA harbors a canonical WxxxE-domain. 
Salmonella SopE effector mimics eukaryotic GEFs by 
stimulation of Rho GTPases Cdc42 (Huang et al., 2009). 
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Salmonella proteins SopE and SopE2, which share 69% amino acid sequence identity, 
represent the second family of bacterial GEFs for Rho GTPases. SopE and SopE2 are shown 
to directly activate Rac1 and Cdc42 in a Dbl-like fashion, resulting in the formation of 
membrane ruffles (Friebel et al., 2001). Although SopE and SopE2 do not share sequence 
similarity with this Rho GEF family, these Salmonella effectors are able to mimic eukaryotic 
GEFs (Buchwald et al., 2002).  
Strikingly, despite the lack of sequence homology between the two families of bacterial GEF-
mimics, structure analysis of the WxxxE-family GEFs and of the Salmonella effectors 
SopE/E2 reveal that these effectors indeed share a common fold (Buchwald et al., 2002; 
Ohlson et al., 2008; Huang et al., 2009; Bulgin et al., 2010). This highlights the importance of 
efficient manipulation of Rho GTPases, because these bacteria independently invent such 
enzymes twice during co-evolution with their hosts. Noteworthy, Salmonella comprises 
bacterial GEFs of both families, namely SopE and -E2 as well as SifA and -B. 
In this study, I focus on several members of the WxxxE group such as Salmonella SifA and 
SifB as well as EspT from EPEC and Citrobacter rodentium. 
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1.11 Aim of the study 
Enteric Gram-negative pathogens utilize T3SS in order to export bacterial virulence proteins 
into host cells. These bacterial effector proteins modulate the host’s actin cytoskeleton for the 
establishment of infection within or beyond the epithelial lining. The role of the secreted 
effectors during infection has been extensively studied in recent years. However, hitherto only 
a few host proteins have been discovered to directly interact with translocated virulence 
factors, most of them remaining unknown.  
This study aims at defining host molecular targets of bacterial virulence factors, including 
SifA, SifB and EspT, and to understand how these bacterial virulence factors manipulate host 
cell signaling pathways.  
In order to achieve this aim we have established the following tasks: 
- validation of the Y2H hits using biochemical methods; 
- mapping of interaction surfaces between a pair of proteins using deletion mutants and 
individual domain-based constructs in pull-down assays; 
- investigation of subcellular localization and studies of co-localization of host and bacterial 
proteins; 
- generation of somatic knockout cells using CRISPR-Cas approach; 
- production of monoclonal antibodies against SifA and SifB;  
- investigation of the role of potential interactions during long-term infection with a wild type 
and a mutant Salmonella enterica serovar Typhimurium using time-lapse microscopy. 
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2. MATERIAL 
2.1 Chemicals 
All used chemicals, reagents and solvents have been purchased from AppliChem GmbH 
(Darmstadt, Germany), Bio-Rad Laboratories GmbH (Munich, Germany), Fluka Chemie AG 
(Buchs, Switzerland), Macherey Nagel (Düren, Germany), Roche Diagnostics GmbH 
(Mannheim, Germany), Sigma-Aldrich Chemie GmbH (Munich, Germany), Thermo Fisher 
Scientific (Schwerte, Germany), Gibco by Life Technologies (Darmstadt, Germany), Polyplus 
transfection (New York, USA), Merck KGaA (Darmstadt, Germany), New England Biolabs 
(Ipswich, MA, USA) and Promega Corporation (Madison, WI, USA). 
 
2.2 Plastic 
Plastic ware has been purchased from Sarstedt (Nümbrecht, Germany). 
 
2.3 Reagents 
 
Table 1: Commercial kits 
Kit Manufacturer 
GeneJET Plasmid Miniprep Kit Thermo Fisher Scientific, Schwerte, Germany 
GeneJET Gel Extraction and DNA 
Cleanup 
Thermo Fisher Scientific, Schwerte, Germany 
Mix2Seq Kit Eurofins Genomics GmbH (Ebersberg, Germany). 
Pierce™ BCA Protein Assay Kit Thermo Fisher Scientific, Schwerte, Germany 
 
Table 2: DNA size markers 
Marker Fragment size, bp Reference 
Quick-Load 100 bp DNA 
Ladder 
1.517; 1.200; 1.000; 900; 
800; 700; 600; 500; 400; 
300; 200; 100 
New England 
Biolabs,Ipswich, MA, USA 
Quick-Load 1 kb DNA 
Ladder 
10.000; 8.000; 6.000; 5.000; 
4.000; 3.000; 2.000; 1.500; 
1.000; 500 
New England 
Biolabs,Ipswich, MA, USA 
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Table 3: Protein size markers 
Marker Fragment size, kDa Reference 
Color Prestained Protein 
Standard, Broad Range 
245; 190; 135; 100; 80; 58; 
46; 32; 25; 22; 17; 11 
New England 
Biolabs,Ipswich, MA, USA 
PageRuler™ Prestained 
Protein Ladder 
180; 130; 100; 70; 55; 40; 
35; 25; 15; 10 
Thermo Fisher Scientific, 
Schwerte, Germany  
 
Table 4: Media and supplements for eukaryotic cell culture 
Reagent Description Reference 
DMEM (1X) Dulbecco´s Modified Eagle Medium 
[+] 4.5 g/L D-Glucose 
[+] L-Glutamine 
[-] Pyruvate 
Gibco, Life Technologies, 
Darmstadt, Germany 
Opti-MEM
®
 (1X) Opti-MEM® I Reduced-Serum 
Medium  
Gibco,Life Technologies, 
Darmstadt, Germany 
Trypsin-EDTA (1X) Trypsin-EDTA (0.05%), phenol red  Gibco, Life Technologies, 
Darmstadt, Germany 
L-Glutamine (100X) 200mM L-Glutamine Gibco,Life Technologies, 
Darmstadt, Germany 
Pen Strep Penicillin-Streptomycin (5,000 U/ml) Gibco,Life Technologies, 
Darmstadt, Germany 
FBS Fetal bovine serum, sterile filtered Sigma-Aldrich Chemie 
GmbH, Munich, Germany 
Gentamicin solution 10 mg/ml in deionized water, liquid, 
sterile filtered  
Sigma-Aldrich Chemie 
GmbH, Munich, Germany 
PBS PBS tablets, Phosphate-Buffered 
Saline 
Gibco, Life Technologies, 
Darmstadt, Germany 
jetPRIME® Transfection reagent Polyplus transfection, New 
York, US 
X-tremeGENE™ 9 Transfection reagent Roche, Mannheim, Germany 
Fibronectin Human plasma fibronectin Roche, Mannheim, Germany 
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2.4 Enzymes 
Table 5: Enzymes 
Enzyme Specific activity Reference 
Go Taq DNA polymerase 5’ → 3’ DNA polymerase Promega Corporation, 
Madison, WI, USA 
Phusion DNA polymerase 5’ → 3’ DNA polymerase 
Generates blunt-ended 
products 
New England 
Biolabs,Ipswich, MA, USA 
T4 DNA ligase Formation of a phosphor-
diester bond between 3’ and 
5’-termini 
New England 
Biolabs,Ipswich, MA, USA 
Restriction enzymes: 
BamH1 5’-G^GATCC-3’ Thermo Fisher Scientific,  
Schwerte, Germany 
BglII 5’-A^GATCT-3’ Thermo Fisher Scientific,  
Schwerte, Germany 
SalI 5’-G^TCGAC-3’ Thermo Fisher Scientific,  
Schwerte, Germany 
Eco47 III 5’-AGC^GCT-3’ Thermo Fisher Scientific,  
Schwerte, Germany 
EcoRV 5’-GAT^ATC-3’ Thermo Fisher Scientific,  
Schwerte, Germany 
Bsp1407I 5’-T^GTA CA-3' Thermo Fisher Scientific,  
Schwerte, Germany 
BbsI 5’-GAAGACN2↓-3' Thermo Fisher Scientific,  
Schwerte, Germany 
Lysozyme from chicken egg 
white 
Glycoside hydrolase Sigma-Aldrich Chemie 
GmbH,Munich, Germany 
Benzonase Endonuclease Merck KGaA, Darmstadt, 
Germany. 
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2.5 Antibodies 
Table 6: Primary antibodies 
Name  Target mc/pc Species  Reference Application 
101G4B2 GFP mc ms Barbara Behrendt, HZI WB 
Ab290 GFP pc rb Abcam WB 
9E10 Myc mc ms Commercial hybridoma, HZI WB, IF 
9B11 Myc mc ms Cell Signaling WB 
 RFP pc rb Jan Faix, MHH WB 
5F8 RFP mc rat Chromotek IF 
HA HA mc ms Covance WB 
Y 1/2 Tubulin mc rat Jürgen Wehland, HZI IF 
20C6 Tubulin pc rb  IF 
ab24586 Golgi  pc rb Abcam IF 
ab136044 CLIP4 pc rb Abcam WB 
HPA043366 CLIP4 pc rb Atlas WB 
7H8/A10, 
7H8/24 
SifA mc ms TU Braunschweig,Sabine 
Buchmeier 
WB 
7B10, 1G12 SifB mc ms TU Braunschweig,Sabine 
Buchmeier 
WB 
 
Abbreviations: mc=monoclonal, pc=polyclonal, rb = rabbit, ms = mouse.  
Antibodies were diluted according to manufacturer’s instructions. 
 
Table 7: Secondary antibodies 
Name  Description Coupled to  Reference Application 
A4a goat anti-mouse IgG & IgM 
(H+L) 
HRPO Dianova WB 1:2000 
B4c goat anti-rabbit IgG (H+L) HRPO Dianova WB 1:2000 
A12c goat anti mouse IgG (H+L) Alexa Fluor
TM
 488 Invitrogen IF 1:100 
A13c goat anti-mouse IgG (H+L) Alexa Fluor
TM 
594 Invitrogen IF 1:100 
A16c goat anti-mouse IgG (H+L) Alexa Fuor
TM 
350 Invitrogen IF 1:100 
B12c goat anti-rabbit IgG (H+L) Alexa Fluor
TM 
488 Invitrogen IF 1:100 
B13c goat anti-rabbit IgG (H+L) Alexa Fuor
TM 
594 Invitrogen IF 1:100 
C13c goat anti-rat IgG (H+L) Alexa Fuor
TM 
594 Invitrogen IF 1:100 
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2.6 Fluorescent dyes 
Table 8: Fluorescent dyes 
Name Description Reference Application 
DAPI 4',6-diamidino-2-phenylindole Invitrogen IF 1:500 
PH12 Phalloidin-Alexa 350 Invitrogen IF 1:100 
PH13 Phalloidin-Alexa 594 Invitrogen IF 1:100 
 
2.7 Oligonucleotide Primers 
 
Designed oligonucleotide primers were synthesized by Eurofins Genomics GmbH (Ebersberg, 
Germany).All primers used in this study are listed in Table 9. 
 
Table 9: List of oligonucleotides 
Oligonucleotide  Purpose Sequence 5’ to 3’ 
CLIP4Xba1fwdBamH1 cloning GGATCCATGCTTCTAGATGCGGTGCCTC 
CLIP4M1252fwdBgl2 cloning AGATCTATGGATGTTGCCCTGCTTGGA 
CLIP41228revSal1 cloning GTCGACTTTCTCTGTCACAGTTTTAAG 
CLIP41849revSal1 cloning GTCGACCTTCACGCTCCCTTCAATG 
pJET1.2 for  sequencing CGACTCACTATAGGGAGAGCGGC 
pJET1.2 rev sequencing AAGAACATCGATTTTCCATGGCAG 
pEGFPC1for sequencing GATCACTCTCGGCATGGAC 
pEGFPC1rev sequencing CATTTTATGTTTCAGGTTCAGGG 
pGex for sequencing ATAGCATGGCCTTTGCAGG 
pGex rev sequencing GAGCTGCATGTGTCAGAGG 
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2.8 Plasmids 
Table 10: Plasmids 
Plasmid AR Function Source  
pEGFP-C1 kana GFP-tagged 
expression vector 
Clontech 
pEGFP C1–APPL1 kana Transfection, IF, Pull 
down assay 
this group 
pEGFP C1-DYNLRB1 kana Transfection, IF, Pull 
down assay 
this group 
pEGFP C1-Cep70 kana Transfection, IF, Pull 
down assay 
this group 
pEGFP C1-CLIP4 kana Transfection, IF, Pull 
down assay 
this group 
pEGFP C1-CLIP4  
∆ANK 
kana Transfection, IF, Pull 
down assay 
this group 
pEGFP C1-CLIP4 
∆CAP-Gly 
kana Transfection, IF, Pull 
down assay 
this group 
pEGFP C1 CLIP4  
(1CAP-Gly) 
kana Transfection, IF, Pull 
down assay 
this dissertation 
pEGFP-CLIP4 
(1+2 CAP-Gly) 
kana Transfection, IF, Pull 
down assay 
this dissertation 
pEGFP-CLIP4 
(2 CAP-Gly) 
kana Transfection, IF, Pull 
down assay 
this dissertation 
pEGFP-CLIP4 
(2+3 CAP-Gly) 
kana Transfection, IF, Pull 
down assay 
this dissertation 
pCB6-GFP-CLIPR5926R amp Transfection, IF, Pull 
down assay 
Franck Perez, 
Severine Divoux 
Institut Curie, 
Paris 
pCB6-GFP-CLIPR59AA amp Transfection, IF, Pull 
down assay 
pEGFP C2-CLIP115  
CAP-Gly 
kana Transfection, 
Pull down assay 
Marco Van Ham, 
HZI 
pEGFP C2-CLIP170  
CAP-Gly 
kana Transfection,  
Pull down assay 
Marco Van Ham, 
HZI 
pmCherry C1 kana RFP-tagged 
expression vector 
Clontech 
pmCherry C1-CLIP4 kana Transfection, IF this dissertation 
pETM-41 kana Protein expression 
vector 
EMBL 
pETM-41-SifA ∆ext kana Protein expression this group 
pETM-41-SifB ∆ext kana Protein expression this group 
pEGFP-C1-SifA ∆ext kana Transfection, IF this group 
pEGFP-C1-SifB ∆ ext  kana Transfection, IF this group 
pRK5-myc-SifB amp Transfection, IF this dissertation 
pSpCas9(BB)-2A-GFP amp cloning Addgene 
 
Abbreviations: AR = encoded antibiotic resistance for selection in bacteria; 
amp = ampicillin; kana = kanamycin; IF=immunofluorescence. 
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2.9 Cell lines and cell culture media 
 
Table 11: List of cell lines 
Cell line  Description 
B16-F1 Mouse melanoma fibroblasts 
NIH/3T3 Mouse embryonic fibroblasts 
Hek 293T Human epithelial embryonic kidney cells 
HeLa Human epithelial carcinoma cells 
A431 Human epithelial carcinoma cells 
Cos-7 African green monkey kidney fibroblasts 
HeLa-LAMP1-GFP Epithelial carcinoma 
 
Table 12: Cell culture media for B16-F1, NIH/3T3, Cos-7, HeLa and A431 cell lines 
Components  
DMEM  
[+] 4.5 g/L D-Glucose 
[+] L-Glutamine 
[-] Pyruvate 
 
FBS 10% (v/v) 
Pen Strep 1% (v/v) 
L-Glutamine 2mM Glutamine 
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2.10 Microorganisms and bacterial growth media 
Table 13: List of microorganisms 
Microorganism Characteristics 
E.coli DH5α fhuA2 Δ(argF-lacZ)U169 phoA glnV44 Φ80 Δ(lacZ)M15 
gyrA96 recA1 relA1 endA1 thi-1 hsdR17 (Invitrogen) 
E.coli BL21 (DE3) fhuA2 [lon] ompT gal (λ DE3) [dcm] ∆hsdS 
λ DE3 = λ sBamHIo ∆EcoRI-B int::(lacI::PlacUV5::T7 
gene1) i21 ∆nin5 (Invitrogen) 
Salmonella enterica serovar 
Typhimurium SL1344 
 
Salmonella enterica serovar 
TyphimuriumMvP389 
∆sifB::FRT (Prof.Dr. Michael Hensel) 
Salmonella enterica serovar 
Typhimurium MvP503 
∆sifA::FRT (Prof.Dr. Michael Hensel) 
 
Tabel 14: Bacterial growth media 
LB medium (“Luria Bertani broth”) 
Trypton 10 g/l  
Yeast extract 5 g/l 
NaCl 7.5 g/l 
 
Table 15: Supplements for bacterial growth media 
Supplement Stock solution Working concentration 
Ampicillin 100 mg/ml, sterile filtered 100 µg/ml 
Kanamycin 30 mg/ml, sterile filtered 30 µg/ml 
Gentamicin 10 mg/ml 100 µg/ml 
Glucose 1 M, sterile filtered 2 g/l  
Isopropyl-ß-D-
thiogalactopyranoside (IPTG) 
1 M, sterile filtered 0.5 mM 
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3. METHODS 
3.1. Molecular biological methods 
3.1.1. LB agar plates 
 
LB agar plates were poured under sterile conditions from an autoclaved LB agar stock (0.4% 
(w/v) agar in LB medium). Appropriate antibiotics were added to the solution once it cooled 
down to about 55°C. Approximately 20 ml of LB agar solution were required per Ø100 mm 
polystyrene Petri dish. 
 
3.1.2. Storage of bacterial strains 
For daily use, bacterial working stocks were streaked onto agar plates, incubated up-side-
down overnight at 37ºC and stored at 4°C for several weeks. For long-term storage, glycerol 
stocks were prepared. To do so, bacterial cultures were supplemented with an appropriate 
volume of glycerol 10% (v/v) during exponential growth phase and then snap-frozen and 
stored at -80°C.  
 
3.1.3. Polymerase chain reaction (PCR) 
In order to successfully amplify the region of interest in a DNA sequence, specific PCR 
primers were designed (Mullis et al., 1986). All reaction components were mixed on ice and 
then quickly transferred to a thermocycler preheated to the denaturation temperature 
(95°C).  Basic reaction components are listed in Table 16. 
Table 16: Basic reaction mixture for PCR 
Component Final Volume Final Concentration 
Nuclease-Free H2O                                                     33 µl  
5xPhusion HF or GC Buffer 10 µl 1X 
10 mM dNTPs 1 µl 200 µM 
10 µM Forward Primer 2.5 µl 0.5 µM 
10 µM Reverse Primer 2.5 µl 0.5 µM 
Template DNA 0.5 µl 0.5µg 
Phusion DNA Polymerase 0.5 µl 1.0 units/ 50µl PCR 
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The standard program used for PCRs is described in Table 17. 
Table 17: Thermocycling conditions for a routine PCR 
Step Temperature Time Number of Cycles 
Initial Denaturation 95°C 2 min      1X 
Denaturation 95°C 20 sec   
20 X Annealing 55°C 1 min 
Extension 72°C 1 min 
Final Extension 72°C 10 min      1 X 
 
Desired PCR products were detected via agarose gel electrophoresis and purified with 
GeneJET Gel Extraction and DNA Cleanup kit (Thermo Fisher Scientific, Schwerte, 
Germany). 
 
3.1.4. Agarose gel electrophoresis 
Agarose gel electrophoresis was applied for effective separation of DNA fragments according 
to their size. The gel was prepared by dissolving agarose powder in heated 1xTAE buffer. The 
solution was then poured into a gel chamber. For detection of DNA fragments in the gel, 5 µl 
of Midori Green (Biozym, # 617004) were added to 100 ml of agarose gel after the solution 
cooled to ~60°C. The appropriate DNA ladder and DNA samples were mixed with Fast digest 
loading buffer (Thermo Fisher Scientific, Schwerte, Germany) before they were loaded onto 
the gel. The electrophoresis was executed at 80-150 V. DNA fragments were detected by 
using a strong UV light source and documented using Gel Image (Intas). Desired DNA 
fragments were excised from the gel for further purification using GeneJET Gel Extraction 
and DNA Cleanup Kits (Thermo Fisher Scientific, Schwerte, Germany). TAE buffer was 
prepared as described in Table 18. 
Tabel 18: TAE buffer 
Stock solution  
2 M Tris base 
1 M Acetic acid 
50 mM EDTA 
 
Methods 
 
29 
 
3.1.5. Plasmid DNA extraction and purification 
Isolation and purification of high quality plasmid DNA from recombinant E.coli cultures was 
carried out by using the GeneJET Plasmid Midiprep Kit (Thermo Fisher Scientific, Schwerte, 
Germany) according to the manufacturer’s instructions. 
 
3.1.6. DNA gel extraction and purification 
DNA was fragmented in an agarose gel and the desired band was excised from the gel with a 
scalpel. Excised DNA was purified by removing the agarose with the GeneJET Gel Extraction 
and DNA Cleanup Kit (Thermo Fisher Scientific, Schwerte, Germany) according to the 
manufacturer’s instructions.  
 
3.1.7. DNA digestion with restriction enzyme 
Plasmid vector and insert were cleaved with suitable restriction enzymes to create blunt-ended 
DNA fragments. Digestion reactions were performed according to the setup listed in Table 19. 
Table 19: Digestion reaction 
Stock solution Amount 
DNA 5 µl 
H2O 3 µl 
10X Fast Digest Buffer 1 µl 
Fast Digest Enzyme 1 µl 
 
The reaction mixture was incubated at 37°C in a heat block for at least 20 min. Afterwards, 
the digestion products were separated using agarose gel electrophoresis and subsequently 
purified. 
 
3.1.8. Dephosphorylation of linearized vectors 
To avoid self-ligation of a vector and therefore reduce the amount of false-positive clones, the 
plasmid was dephosphorylated. Dephosphorylation of the cleaved vector was accomplished 
using Antarctic phosphatase (New England Biolabs, Ipswich, MA, USA) in 1x Antarctic 
phosphatase reaction buffer. The reaction mixture was incubated at 37°C for 15 min and 
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inactivated by heating at 70°C for 5 min. The dephosphorylated vector and the insert were 
separated in an agarose gel, purified and subjected to ligation.  
 
3.1.9. Ligation of DNA fragment and vector 
Ligation was the final step in the construction of a recombinant plasmid. This approach 
allowed the integration of an insert DNA into a compatibly cleaved vector backbone. Ligation 
was performed according to the setup listed in Table 20. 
Tabel 20: Ligation reaction 
Stock solution Amount 
Vector 1 µl 
Insert 7 µl 
10X T4 DNA Ligase Buffer 1 µl 
T4 DNA Ligase 1 µl 
 
Ligation reactions were performed overnight at 16°C in a sterile PCR tube. Upon completion 
of the reaction, 5 µl of the ligated DNA were used to transform electro-competent E. coli 
DH5α. Transformed bacteria were then plated on LB agar containing the appropriate 
antibiotic. Positive clones were selected by means of digestion analysis of plasmid DNA and 
finally verified by sequencing.  
 
3.1.10. Generation of electrocompetent E.coli 
E.coli DH5α were streaked on LB plates and grown overnight at 37°C. The next day a single 
colony was used to inoculate 3-5ml of LB medium. This culture was again incubated at 37°C 
overnight and subsequently diluted 1:100 - 1:500 in 0.5-1 L of LB medium. The resulting 
culture was grown for approximately 18 h at room temperature with agitation (1000 rpm) 
until the optical density (OD600nm) reached 0.6-1. Afterwards, the cell suspension was 
chilled on ice for at least 15 min and bacteria were harvested by centrifugation at 8000 rpm 
and 4°C for 10 min (JA-10 rotor, Beckman Avanti J-25 centrifuge). The cell pellet was 
resuspended in 200 ml of cold sterile water. This washing procedure was repeated 3 times. 
Finally, the pelleted cells were resuspended by gentle pipetting in 3-6 ml ice-cold 15% (v/v) 
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glycerol and aliquoted into individual pre-chilled microfuge tubes. The aliquots were then 
snap-frozen in liquid nitrogen and stored at -80°C. 
 
3.1.11. Transformation of electro-competent E.coli 
A 50 µl aliquot of electro-competent bacterial cells was thawed on ice and mixed by pipetting 
with 1 µg of salt-free plasmid DNA. This mixture was then transferred to a pre-chilled 
electroporation cuvette, and the cells were subjected to electroporation (Gene Pulser® II 
Electroporation System, BIO-RAD) according to the manufacturer’s instructions. 
Immediately after the pulse, 1 ml of room temperature LB medium was added, and the cells 
were allowed to recover at 37°C for 1 h in a shaker.  Bacteria were then pelleted (12000 rpm, 
1min, Centrifuge 5427R from Eppendorf) and resuspended in 50-100µl of LB medium. 
Finally, the cells were plated on a pre-warmed LB-agar plate containing the appropriate 
antibiotic incubated up-side-down overnight at 37ºC. 
 
3.1.12. DNA Quantification 
A DS-11 Spectrophotometer (DeNovix Inc., Wilmington, DE USA) was used to quantify 
nucleic acid samples based upon their absorbance value at 260 nm. 
 
3.1.13. DNA sequencing 
DNA sequencing was carried out by Eurofins Genomics GmbH (Ebersberg, Germany). The 
sequences were analyzed using the Basic Local Alignment Search Tool (BLAST, 
http://blast.ncbi.nlm.nih.gov/Blast.cgi) and the free software ApE, a plasmid editor 
(http://biologylabs.utah.edu/jorgensen/wayned/ape/). 
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3.2. Cell biological methods 
3.2.1. Culture of eukaryotic cells 
For sterile conditions, subculturing of eukaryotic cell lines took place under a laminar-flow 
hood (Maxisafe 2020, Thermo Scientific, Langenselbold, Germany). Cells were maintained in 
appropriate medium in a sterile Ø100 mm dish. Upon reaching confluency, the cell monolayer 
was washed twice with room temperature PBS, covered with pre-warmed Trypsin (0.05 %) 
and incubated at 37°C until cells detached. Next, the cells were resuspended in pre-warmed 
medium and centrifuged at room temperature (5 min, 1000 rpm, Centrifuge 5804 R from 
Eppendorf). Finally the cell pellet was resuspended in complete growth medium and cells 
were seeded at a dilution of 1/5 or/and 1/10. Cell lines were subcultured up to 3 months and 
then a new cryovial of cells was thawed. 
 
3.2.2. Thawing of cryoconserved eukaryotic cells 
A cryovial of frozen cells was thawed rapidly in a water bath at 37°C for max. 1 min. The 
freezing medium was diluted slowly by adding pre-warmed growth medium. Cells were 
pelleted (5 min, 1000 rpm, Centrifuge 5804 R from Eppendorf) and finally resuspended in a 
proper volume of growth medium. Thawed cells were seeded into sterile Ø100 mm dishes. 
The growth of eukaryotic cells was controlled under the light microscope. 
 
3.2.3. Freezing and storage of eukaryotic cells 
For long-term storage, eukaryotic cells were expanded and then cryopreserved as early as 
possible.  Cells were frozen slowly by reducing the temperature by approximately 1°C per 
minute using a cryo-freezing container (CoolCell® Cryopreservation Alcohol-Free Cell 
Freezing Containers, BioCision®, USA). The freezing medium contained 10% DMSO as a 
cryoprotective agent. The next day, cryovials were transferred to liquid nitrogen and stored in 
the gas phase. 
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3.2.4. Transfection of Eukaryotic Cells 
The transfer of nucleic acids (DNA or RNA) into living cells has been referred to as 
transfection. Cells that had been seeded the day before were transfected at a stage of 60-80% 
confluency. Transfections with the commercial lipid-based agents jetPRIME® (Polyplus-
transfection, New York, US) or X-tremeGENE™ 9 (Roche, Mannheim, Germany) were 
carried out according to the manufacturer’s recommendations. 
Briefly, X amount of plasmid DNA were diluted in W volume of buffer, then Y volume of 
transfection reagent was added to the mixture (Table 21 and Table 22). This master mix was 
vortexed for 10 s and spun down, incubated for 10 min at room temperature and added to the 
cells. Rocking the plate back and forth allowed gentle mixing of the components. 
Table 21: DNA transfection using jetPRIME® 
Culture vessel W volume of 
jetPRIME® buffer 
X amount of 
DNA added 
Y volume of  
jetPRIME® reagent 
24-well 50 µl 0.5 µg 1µl 
6-well/35mm 200 µl 2 µg 4 µl 
100 mm 500 µl 10 µg 20 µl 
 
Table 22: DNA transfection using X-tremeGENE™ 9 
Culture vessel W volume of  
Opti-MEM
®
 
X amount of 
DNA added 
Y volume of   
X-tremeGENE™ 9 reagent 
24-well 50 µl 0.25 µg 0.75 µl 
6-well/35mm 200 µl 1 µg 3 µl 
100 mm 500 µl 5 µg 15 µl 
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3.3. Biochemical Methods 
3.3.1. Bradford-Test 
Protein concentration was determined via Bradford assay (Bradford, 1976). First, several 
dilutions of a protein standard (BSA) in a range of 2 to 10 µg protein were prepared as 
described in Table 23. 
 
Table 23: Bradford assay set up 
                       BSA concentration 
Stock solution Blank 2 µg/µl 4 µg/µl 6 µg/µl 8 µg/µl 10 µg/µl 
       
H2O 800 µl 798 µl 796 µl 794 µl 792 µl 790 µl 
BSA/Protein  0 2 µl 4 µl 6 µl 8 µl 10 µl 
Bradford 200 µl 200 µl 200 µl 200 µl 200 µl 200 µl 
 
Standard solution and samples were transferred into new test tubes and incubated with the 
Bradford solution, as shown in Table 23, for 15 min. Next, 200µl of each standard or sample 
were placed in a 96 well microplate in duplicates. The absorbance was measured at 595 nm on 
a plate reader (VICTOR™ X 5 Multilabel Plate Reader, Perkin Elmer™, USA). Microsoft 
Excel software was used to create a correlation curve and determine the protein concentration 
of the sample. 
 
3.3.2. Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) 
For the best resolution of respective proteins, 7.5%-15% SDS- polyacrylamide gels were 
prepared by using the Mini PROTEAN
®
 3 System (BIO-RAD, Munich, Germany) (Laemmli, 
1970). First, the resolving gel mixture was prepared as listed in Table 24, poured between two 
clean glass plates and left to polymerize. To avoid bubbles and for the even edge of the 
resolving gel, isopropanol was added. After 30 min, isopropanol was discarded and the 
stacking gel was poured as listed in Table 25. Gels were used directly or stored wrapped in 
wet tissue paper in a plastic bag at 4°C. Equal amounts of protein were loaded onto SDS-
PAGE gels along with prestained protein ladder. Afterwards, the gel was subjected to an 
electric field of 100 V for 2 h or 200 V for 1 h. 
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Table 24: SDS-PAGE mixture for two resolving mini-gels 
Stock solution 7.5% 10% 12% 15% 
30% Acrylamide/ 0.8% Bisacrylamide (37.5:1) 4.6 ml 6.6 ml 8 ml 10 ml 
1.5M Tris pH 8.8 5 ml 5 ml 5 ml 5 ml 
H2O 10.2 ml 8.2 ml 6.8 ml 4.8 ml 
10%w/v SDS 200 µl 200 µl 200 µl 200 µl 
10% w/v APS 100 µl 100 µl 100 µl 100 µl 
TEMED 10 µl 10 µl 10 µl 10 µl 
 
Table 25: SDS-PAGE mixture for two stacking mini-gels 
 
 
 
 
 
 
Table 26: SDS running buffer 
 
 
 
 
 
 
 
 
 
 
 
 
Stock solution  
30% Acrylamide/  
0.8% Bisacrylamide (37.5:1) 
650 µl 
0.5M Tris pH 6.8 1.25 ml 
H2O 3.05 ml 
10% w/v SDS 50 µl 
10% w/v APS 25 µl 
TEMED 5 µl 
Stock solution 
25 mM Tris base 
192 mM Glycine 
0.1 % (v/v) SDS 
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3.3.3. Protein staining with Coomassie 
To visualize proteins separated by gel electrophoresis, SDS gels were stained by soaking in 
the Coomassie Brilliant Blue R-250 solution (Table 27). After one hour of incubation gels 
were incubated in destaining solution to reduce background (Table 28). Finally, the gel was 
washed in H2Odd and documented using a scanner (HP Scanjet G2710).The Adobe
®
 
Photoshop CS6 Extended software was used to analyze the stained proteins. 
 
Table27: Coomassie Brilliant Blue solution 
Stock solution % 
Coomassie R-250 0.1% (w/v) 
Acetic Acid 10% (v/v) 
Methanol 25% (v/v) 
H2Odd 65% (v/v) 
 
Table28: Coomassie destaining solution 
 
 
 
 
 
Stock solution % 
  
Acetic Acid 10% (v/v) 
Methanol 40% (v/v) 
H2Odd 50% (v/v) 
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3.3.4. Expression of recombinant proteins 
For high-level protein production, the recombinant plasmid was introduced into electro-
competent E.coli BL21 (DE3) and the transformants were selected on agar plates containing 
the respective antibiotic.  To prepare a pre-culture, 50 ml of LB medium supplemented with 
the appropriate antibiotic were inoculated with a single colony and cultured overnight at 
37°C. The next morning bacteria were diluted 1:10 in 500 ml LB medium supplemented with 
2 g/l glucose and the antibiotic, and grown at 37°C to an OD600 of 0.5-0.8. Expression of the 
recombinant protein was induced with 0.5 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) 
overnight at 20°C. Next, the bacterial culture was harvested by centrifugation at 6000 rpm for 
20 min at 4°C (JA-10 rotor, Beckman Avanti J-25 centrifuge) and resuspended in 10 ml of ice 
cold lysis buffer supplemented with a spatula tip of lysozyme (Table 29). The suspension was 
incubated at 4°C with rotary agitation for 15 min. The cells were disrupted by ultrasonic 
treatment on ice (5 pulses, 30 sec each, with 1 min pause between each round of sonification, 
Branson Sonifer 250); cell debris was removed by centrifugation at 14000 rpm for 30 min at 
4°C (JA-17 rotor, Beckman Avanti J-25 centrifuge). Meanwhile, 500 µl of Ni-NTA agarose 
beads (Qiagen, Hilden, Germany) were loaded onto a PD10 plastic column and equilibrated 
with two column volumes of wash buffer (Table 30). Afterwards, the bacterial supernatant 
was mixed with the beads and incubated overnight at 4°C on a rotary wheel. Next, beads were 
washed with 100 ml of washing buffer containing 20 mM Imidazole to remove unbound 
components and resuspended in 2 ml resuspension buffer. The aliquots of the immobilized 
protein were frozen in liquid nitrogen and stored at −80°C. To confirm the expression of the 
fusion protein, sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was 
applied. After every purification step, samples were taken and prepared for SDS-PAGE. For 
that purpose, the samples were mixed with 4xSDS PAGE sample buffer, boiled for 5 min at 
95°C and loaded on a gel. Using Coomassie staining, the size of the protein as well as the 
intensity of the bands and the purity of the samples could be checked. 
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Table29: Lysis buffer (10 ml) 
Stock solution 
50 mM NaH2PO4 
300 mM NaCl 
10 mM Imidazol 
set pH 8.0 using NaOH 
10 mM β-Mercaptoethanol 
1 µl Benzonase 
1x Protease inhibitor cocktail EDTA free 
Spatula tip of lysozyme 
 
Table30: Washing buffer 
Stock solution 
50 mM NaH2PO4 
300 mM NaCl 
20 mM Imidazol 
set pH 8.0 using NaOH 
0.05% (v/v) Triton X-100 
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3.3.5. Pull-down Assay 
One method to determine the physical interaction between two or more proteins was the pull-
down assay. The minimal requirements for this technique were purified recombinant fusion-
tagged protein (the bait) and a protein-binding partner (the prey). One day prior to the 
experiment, HEK293T or B16-F1 cells were transfected with the plasmid of interest and 
incubated overnight under normal cell culture conditions. The next day, the cells were washed 
twice with PBS on ice, lysed in 500 µl of ice-cold IP buffer (Table 32) and removed from the 
plate using a cell scraper. The lysed cells were incubated on ice for 15 min and centrifuged at 
4°C (15 min, 12000 rpm, Centrifuge 5427R from Eppendorf) to pellet the cellular debris. 50µl 
of the supernatant were taken as a loading control. Immobilized His-MBP-beads bound to 
prey protein were rotated on a rocking platform at 4°C for 2 h. Next, this complex was 
centrifuged at 4°C (500xg, 5 min, Centrifuge 5427R from Eppendorf) and the supernatant was 
discarded. Beads were collected by brief centrifugation and washed three times in ice cold 
IP-buffer containing 1 % Triton X-100 but no protease inhibitor. Washed beads were 
resuspended in 4x SDS PAGE sample buffer (Table 31), boiled for 5 min at 95°C and loaded 
on a gel. Results of Pull-down assays were verified by Western blotanalysis. 
 
Table 31: 4x SDS sample buffer 
 
 
 
 
 
 
 
 
 
 
 
Stock solution 
25 mM Tris pH 6.8 (HCl) 
29 % (v/v) Glycerin 
3.3 % (v/v) SDS 
3.3 % (v/v) 2-Mercaptoethanol 
0.17 % (w/v) Bromphenolblue 
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Table 32: IP-Buffers 
IP buffer „A“ standard   IP-Buffer „B“ ‘lipid friendly’ 
Stock solution  Stock solution 
15 mM KCl  15 mM KCl 
50 mM NaCl  50 mM NaCl 
8 mM Tris, free base  8 mM Tris, free base 
12 mM Hepes, free base  12 mM Hepes, free base 
5 mM MgCl2  5 mM MgCl2 
Added freshly before use:  Added freshly before use: 
1x Protease inhibitor cocktail EDTA free  1x Protease inhibitor cocktail EDTA free 
1% (v/v) Triton X 100  ultrasonic treatment on ice (5 pulses, 30 sec 
each, Branson Sonifer 250  
  
 
   
IP-Buffer „C“   IP-Buffer „D“  
Stock solution  Stock solution 
15 mM KCl  30 mM KCl 
50 mM NaCl  150 mM NaCl 
8 mM Tris, free base  8 mM Tris, free base 
12 mM Hepes, free base  12 mM Hepes, free base 
1mM  EDTA  5 mM MgCl2 
Added freshly before use:  Added freshly before use: 
1x Protease inhibitor cocktail EDTA free  1x Protease inhibitor cocktail EDTA free 
1% (v/v) Triton X 100  1% (v/v) Triton X 100 
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3.4. Immunological methods 
3.4.1. Generation of monoclonal antibodies 
For the generation of monoclonal anti-SifA and anti-SifB antibodies, HisMBP-SifA and SifB 
were expressed and purified by pull down assays as described in 3.3.5. To concentrate 
samples for immunization of mice, the ultrafiltration concentrators Vivaspin
®
6 PES 
membranes (Viva Products) with a cutoff of 10.000 Da were used. The subsequent 
immunization of a mouse with the protein of interest was done at the Antibody Facility of the 
TU Braunschweig by Sabine Buchmeier. 
 
3.4.2. Immunofluorescence microscopy 
3.4.2.1. Preparation of coverslips 
At first, coverslips (∅12 mm or 15 mm) were soaked in a mixture of 60% ethanol (v/v) and 
40% hydrochloric acid (v/v) for at least 30 min, repeatedly washed with H2Odd at room 
temperature and then dried and autoclaved. Next, sterilized coverslips were carefully placed 
into the wells of a microplate. Afterward, the coverslips were coated with fibronectin (1 
mg/ml in 2 M urea, Roche, Mannheim, Germany) to promote adhesion of cells to the glass 
surface, and incubated for 1 h at room temperature. After three washing steps with PBS, the 
cells were seeded in an appropriate growth medium onto the coated coverslips and incubated 
in normal cell culture conditions. Cells were fixed the next day. 
 
3.4.2.2. Fixation of samples 
In order to detect intracellular antigens, cells were previously fixed with pre-warmed 4% 
(w/v) paraformaldehyde (PFA) in PBS at 37°C for 20 min. Afterwards, cells were 
permeabilized with 0.1% Triton X-100 in PBS at room temperature for up to 1 min. Finally, 
the permeabilized cells were washed several times with PBS. 
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3.4.2.3. Immunofluorescence staining 
To avoid non-specific staining, coverslips were incubated for 1 h at room temperature in 
blocking solution (5% horse serum in PBS containing 1% BSA). After several washing steps 
with PBS, coverslips were placed upside down on a 15 µl drop of diluted primary antibody in 
PBS containing 1% BSA and incubated for 1 h. The washing procedure was repeated and 
samples were then incubated with the respective secondary antibody in PBS containing 1% 
BSA, supplemented with Phalloidin and/or Dapi (4',6-diamidino-2-phenylindole) if required. 
At this step, in order to protect the fluorescent dyes from light, coverslips were incubated for 
1 h in the dark and then washed three times with PBS. One drop of Mowiol or ProLong
®
Gold 
antifade reagent (Thermo Scientific, Schwerte, Germany) was dispensed onto a glass slide 
and coverslips were carefully mounted upside-down with the cells facing the glass slide. 
Finally, the samples were dried at room temperature for 1 h and then stored in a slide box at 
4°C.  
 
3.4.2.4. Image acquisition 
Imaging studies were done using an inverted microscope (Axiovert 135TV, Zeiss) equipped 
for epifluorescence and phase-contrast microscopy. Image acquisition was performed using a 
63X objective Plan-Neofluar (Carl Zeiss) equipped with an HXP 120 lamp (Kubler) for 
epifluorescence illumination; the refraction index of the employed immersion oil (Carl Zeiss) 
was 1.518. Images were acquired with a back-illuminated, cooled charge-coupled-device 
(CCD) Coolsnap-K4 camera (Photometrics) driven by Metamorph software (Molecular 
Devices Corp.). Primary images were stored as a TIFF format and refined using ImageJ, 
Adobe
®
 Photoshop CS6 Extended software, Metamorph. 
 
3.4.2.5. Time-lapse microscopy  
The time-lapse experiments were carried out at the Nikon BioStation IM which provides 
consistent environmental control of temperature, humidity and gas concentration in 
combination with phase and fluorescence imaging. 
To study formation and dynamics of SIFs during infection with WT and mutant Salmonella 
strains, HeLa cells constitutively expressing LAMP1-GFP were used. These cells were plated 
on a µ-dish 
35mm, high
 glass bottom (Ibidi) 24 hours before the experiment to obtain 80% 
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confluency at the time of transfection. The next day, HeLa cells were transfected as described 
in chapter 3.2.4. To visualize CLIP4 for live cell imaging, transfection with the pmCherry-C1 
plasmid was performed. The next morning, transfection efficiency was determined by using 
EVOS fluorescence microscopy with red and green channels. Hereafter, infection with 
various Salmonella strains was performed as described in the chapter ‘Bacterial infection’. 
The time-lapse microscopy was carried out 2 h post infection with Salmonella WT or mutant 
strains defective in single effector. The interval between recording images was 5-10 min for 
the duration of 8-12 h.Image data were analyzed by the following software: ImageJ, Adobe
®
 
Photoshop CS6 Extended software and Metamorph. 
 
3.4.3. Western blotting 
Western blotting allowed for identification of specific proteins from a complex protein 
mixture which have been separated by SDS-PAGE. The Thermo Scientific™ Pierce™ G2 
Fast Blotter (Thermo Fisher Scientific, Schwerte, Germany) was employed to transfer 
proteins onto a membrane. First, sheets of Whatman paper and PVDF membrane were 
equilibrated in Pierce 1-Step Transfer Buffer for a minimum of 5 min. Prior to equilibration, 
the PVDF membrane was activated with methanol. Afterwards, the transfer stack was 
assembled as follows: one sheet of ~1.5 mm thick Whatman paper on the bottom (anode), 
followed by membrane, gel and one sheet of ~1.5 mm thick Whatman paper on top. The blot 
roller was used to remove any trapped air bubbles. Then an appropriate fast-blotting program 
was chosen for transfer. The successful transfer of proteins onto the membrane was confirmed 
by soaking in the Ponceau S solution before the blocking step. The membrane was blocked in 
10% (w/v) milk powder in TBS-T for 30 min at room temperature and incubated with primary 
antibody at 4°C overnight on a shaker. On the following day, the blot was washed three times 
in TBS-T before it was incubated with a secondary antibody conjugated with horseradish 
peroxidase (PO) for 1 h at room temperature on a shaker. Afterwards, the blot was washed 
again three times in TBS-T and one time in H2Odd.Finally LumiLight Western Blotting 
Substrate (Roche, Mannheim, Germany) was added to the membrane. The exposure rate of 
the membrane in Intas ECL Chemocam Imager lasted from 5 seconds to 30 minutes. Finally, 
analysis of protein bands was carried out using the Adobe
®
 Photoshop CS6. 
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Table 33: TBS(-T) 
Stock solution 
0.2 M Tris base 
1.37 M NaCl 
set pH 7.6 using HCl 
0.1% (v/v) Tween 20 
 
Table 34: Ponceau S solution 
Stock solution 
5 g Ponceau-S 
0.4% (v/v) Methanol 
15 % (v/v) Acetic acid 
 
3.5. Bacterial infections 
For infection assays, cells were maintained in antibiotic-free growth medium. Overnight 
bacterial cultures were diluted 1:100 in 5 ml LB medium and grown at 37°C to an OD600 of 
0.5-0.8. Before infection, bacteria were harvested by centrifugation at 12000 rpm for 3 min 
(Heraeus™ Pico™ Micro centrifuge Thermo Fisher Scientific, Schwerte, Germany), washed 
once in the sterile PBS, and diluted 1:100 in antibiotic-free tissue culture medium.Cells were 
infected at a multiplicity of infection (MOI) of 50. After inoculation, the plates were 
centrifuged (5min at 2000 rpm in Centrifuge 5810 from Eppendorf) to initiate contact 
between bacteria and epithelial cells. 20 min after infection (37°C, 5 % CO2 in Nuaire 
incubator NU-5800E,Tecnomara GmbH, Fernwald, Germany) cells were washed several 
times with antibiotic-free tissue culture medium and incubated for 1 h in medium containing 
100 µg/ml gentamycin to kill any extracellular bacteria. The cells were washed again and 
growth medium containing 10 µg/ml gentamycin was used for further culturing during the 
infection assay 
For live cell imaging, the cell culture dish was placed on the Nikon BioStation IM as 
described in part 3.4.2.5.  
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3.6. Generation of a knockout CLIP4 cell line using the CRISPR/Cas9 system 
The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Type II system,  a 
bacterial immune system, had been modified for genome editing (Ran et al., 2013).The 
CRISPR design web tool (http://crispr.mit.edu/) was employed to create the appropriate guide 
RNA (∼20 nucleotides) which defines the location of the genomic target. To generate 
pSpCas9 (sgRNA), a pair of annealed oligonucleotides was ligated into the expression 
plasmid pSpCas9 (BB)-2A-green fluorescent protein (GFP). 
Table 35: Annealing buffer 
Stock solution 
100 mM KAc ( Potassium acetate) 
2 mM MgAc (Magnesium acetat)  
30 mM HEPES 
set pH 7.4 
 
Table 36: Annealing of the oligonucleotides 
Stock solution 
1µl Design forward primer 
1 µl Design reverse primer 
48 µl Annealing buffer 
 
The annealing reaction mixture was first incubated at 95°C for 4 min, then at 70°Cfor 10 min, 
then slowly cooled down and stored on ice. 
The digestion reaction of the pSpCas9 (BB)-2A-GFP vector was performed according to the 
setup listed in Table 37. 
Table 37: Digestion reaction of the pSpCas9 (BB)-2A-GFP vector 
Stock solution Amount 
DNA (pSpCas9(BB)-2A-GFP) 3 µl 
H2O 22 µl 
10X Fast Digest Buffer 3 µl 
Fast Digest Enzyme (BbsI) 1 µl 
 
The reaction mixture was incubated at 37°C in a heat block for at least 20 min. Afterwards, 
the digestion products were separated using agarose gel electrophoresis and then purified 
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using GeneJET Gel Extraction and DNA Cleanup kit (Thermo Fisher Scientific, Schwerte, 
Germany).Ligation reaction of DNA fragment and vector was performed as described in 
3.1.9. Finally, the ligation product was transformed into electro-competent E. coli DH5α. 
Plasmid DNA was isolated using GeneJET Plasmid Miniprep Kit (Thermo Fisher Scientific, 
Schwerte, Germany) according to the manufacturer’s instructions. The DNA concentration 
was quantified using a DS-11 Spectrophotometer (DeNovix Inc., Wilmington, DE USA). 
Samples were analyzed by double digestion using BbsI and EcoRV restriction enzymes. 
Afterwards a 1% (w/v) agarose gel containing the samples was subjected to an electric field of 
100 V. Finally selected samples were sequenced by Eurofins Genomics GmbH (Ebersberg, 
Germany) to identify positive clones. The sequencing results were analyzed using the free 
software ApE a plasmid editor (http://biologylabs.utah.edu/jorgensen/wayned/ape/). To 
generate CLIP4 knockout cell lines, NIH/3T3 and A431 cells were transfected with 
appropriate plasmid DNA using X-tremeGENE™ 9 transfection reagent (Roche, Penzberg, 
Germany). Medium was changed after 48 h post transfection, cells were washed twice with 
PBS, trypsinized, centrifuged (5 min, 1000 rpm, Centrifuge 5804 R from Eppendorf) and 
resuspended in 1 ml growth medium supplemented with Penicillin-Streptomycin. Non-
transfected WT A431 cells served as control samples for fluorescence activated cell sorting 
(FACS). FACS Sorting was carried out by Lothar Gröbe (HZI, Braunschweig). Cells were 
sorted and seeded as single cells into normal growth medium on 96-well plates. Single cell 
clones were expanded stepwise and cryopreserved as described in 3.2.3. Western Blot 
analysis was used to determine if the gene of interest was successfully knocked out by the 
CRISPR/Cas 9 system.  
 
3.7 Isolation of primary mouse tissues 
Preparation of murine tissues was performed by Stephanie Stahnke (HZI, Braunschweig). 
Briefly, an 8 weeks old mouse (strain C57BL/6, commonly referred to as “black 6” mice) was 
sacrificed via CO2 inhalation. To avoid protein destruction during enzymatic lysis of tissue, 
cryogenic grinding was performed. For that, a ceramic mortar and a pestle were pre-chilled 
with liquid nitrogen and the dissected tissues (skin, spleen, lung, kidney, liver, intestine (large 
and small), stomach and pancreas) were snap-frozen in liquid nitrogen. Finally, tissues were 
ground to fine powder, transferred to a pre-chilled cryo-tube, and the specimens were stored 
at - 80°C. The samples were mixed with 4xSDS-PAGE sample buffer, boiled and analyzed by 
Western blotting. 
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4. RESULTS 
4.1 Identification of novel interactors by performing a Yeast-2-Hybrid screening 
Project I focused on the identification of potential host binding partners of different bacterial 
virulence factors and the characterization of their function. In this perspective, the lab had 
initially performed Y2H screening in collaboration with the German Cancer Research Centre 
in Heidelberg in order to generate a list of potential effector binding partners. Using this 
approach, a human cDNA-based protein library served as prey and full-length or truncated 
versions of WxxxE bacterial effector proteins SifA and SifB of Salmonella, and EspT from 
enteropathogenic E. coli (EPEC) and Citrobacter rodentium, were used as baits. Remarkably, 
SifA and SifB shared an extension at the N-terminal region, which - in the case of SifA- 
required for the formation of highly dynamic tubules, so-called SIFs, which extended from the 
SCV, in addition to the WxxxE-GEF-like domain at the C-terminal region. The spectrum of 
host proteins that binded to the above bacterial virulence factors was explored using the Y2H 
screening approach, and the final list of putative interaction partners was about 30 hits per 
bait. Prior to any experimental validation, we carefully considered the biological function of 
these potential interaction partners. Involvement of these host proteins in such fundamental 
processes as migration, endocytosis, and cellular transport made them highly interesting 
candidates for our research.  
As a result of the procedure described above, four host-pathogen pairs were pre-selected 
based on the known or anticipated biological relevance of these host proteins. These pre-
selected Y2H hits are presented in Table 38. 
Table 38: List of most promising host-pathogen interactions 
Bait Prey Prey function 
EspT APPL1 Adaptor protein 
SifA Cep70 Centrosomal protein 
SifA DYNLRB1 Dynein Light Chain protein 
SifB CLIP4 CAP-GLY domain containing linker protein 4 
 
A combination of different methods, such as pull-down assay, co-immunoprecipitation assay 
and co-localization analysis by fluorescence microscopy, was used to validate the Y2H hits 
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and to gain more insight into biological activities of these virulence factors. Looking for the 
interaction partners of WxxxE effector proteins, in our experimental setup we used truncated 
versions of SifA and SifB (SifA ∆ext and SifB ∆ext) that harbored the WxxxE sequence 
motif. 
Hence, the current project was aimed at defining the molecular targets of SifA, SifB and EspT 
and trying to understand how these bacterial virulence factors manipulate host cell signaling 
pathways. 
 
4.2 Expression and purification of recombinant fusion proteins 
In order to verify physical interaction between a presumable host target protein and its 
corresponding bacterial factor in pull-down assays, we expressed recombinantly the bacterial 
effector protein of interest. For this purpose, all recombinant proteins were overexpressed as 
His-MBP fusion proteins in E. coli BL21 (DE3) according to standard procedures (chapter 
3.3.4). Purification of the proteins was carried out as described in chapter 3.3.4. Samples from 
every purification step were collected and then analyzed by SDS gel electrophoresis (chapter 
3.3.2, 3.3.3). The results of the SDS-PAGE analyses of the purified recombinant proteins have 
been depicted in Figure 10. 
 
 
 
 
 
 
 
 
 
Figure 10: SDS-PAGE analysis of expression and purification steps of recombinant SifA, SifB and EspT fusion 
proteins.  
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Recombinant proteins were expressed in E. coli BL21 (DE3) as 6xHis-tagged fusion proteins using the pET-41-vector and 
purified. Gels were stained with Coomassie Brilliant Blue R-250. (A) Expression of a 45 kDa His-MBP. (B) Expression of a 
72 kDa recombinant SifA ∆ext protein that contain WxxxE-GEF-like domain. (C) Expression of a 71 kDa recombinant SifB 
∆ext protein that harbor WxxxE motif. (D) Expression of a 68 kDa recombinant EspT protein. Lanes are loaded as follows: 1. 
Prestained protein ladder; 2. Sample before induction; 3. Sample after induction; 4. Insoluble fraction after ultrasonication; 5. 
Soluble fraction after ultrasonication; 6. Supernatant after coupling to His-MBP beads; 7. His-MBP beads 5µl; 8. His-MBP 
beads 7µl; 9. His-MBP beads 10µl; 10. His-MBP beads 15µl; 11. Unstained protein ladder. 
 
The His-tagged maltose-binding protein (MBP) encoded on the pET-41-vector, had a 
molecular weight of 45 kDa and could be immobilized either on amylose resin, or on Ni-NTA 
affinity resin. SDS-PAGE-analysis of the purification samples of His-MBP-SifA ∆ext 
confirmed the calculated molecular weight of the protein 72 kDa (Figure 10 B). Also His-
MBP-SifB ∆ext (Figure 10 C) appeared as a band of the calculated molecular weight of 71 
kDa. The recombinant EspT protein was detected as a band of approximately 68 kDa, which 
was in agreement with the calculated size of His-MBP-EspT (Figure 10 D). The purified 
recombinant proteins were then used for pull-down assays and antibody production. 
 
4. 3 Bacterial virulence factor EspT and its predicted molecular target APPL1 
An adaptor protein termed phosphotyrosine interacting with PH domain and leucine zipper 1 
(APPL1) was identified as a possible interaction partner of EspT. APPL has been described to 
possess two isoforms, APPL1 and APPL2, both of which interact with Rab5, an important 
regulator of endocytosis, through the N-terminal BAR-PH domain (Miaczynska et al., 2004; 
Zhu et al., 2007; Li et al., 2007). APPL was originally identified as an interacting partner of 
the oncoprotein serine/threonine kinase AKT2 (Mitsuuchi et al., 1999). APPL interacts with 
the tumor suppressor protein DCC (deleted in colorectal cancer), and therefore it has been 
referred to as DCC-interacting protein (DIP)-13a (Liu et al., 2002; Li et al., 2007). In addition, 
APPL1 has been reported as a multifunctional endosomal adaptor protein (Nechamen et al., 
2007). APPL1 composed a BAR domain (initially identified as the leucine zipper motif), a PH 
domain and a PTB domain (Figure 11).  
 
Figure 11: Schematic representation of human APPL1 domain structure. APPL1 harbors unique BAR domain that 
contains two four-helical bundles (Li et al., 2007). The PTB domain of APPL1 interacts with both Akt2 (Mitsuuchi et al., 
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1999) and the adiponectin receptors AdipoR1 and AdipoR2 (Mao et al., 2006). Interaction between APPL1 and Rab5 is 
mediated by the BAR-PH domain (Miaczynska et al., 2004). 
 
To further investigate the ability of APPL1 to interact with EspT, pull-down assays were 
performed, in which purified recombinant His-MBP-EspT was used as bait and incubated 
with B16-F1 cell lysates of ectopically expressing GFP-APPL1 as prey. As a negative control 
for the experiment, His-MBP alone was used. Representative results of biochemical analyses 
have been illustrated in Figure 12. 
 
 
 
 
 
 
 
The Western blot result revealed that APPL1 was readily expressed and soluble, but does not 
bind to immobilized EspT under given conditions. GFP-APPL1 was detected by a 
monoclonal GFP antibody. Four different buffer conditions were tested, however no binding 
could be observed. 
Taken together, the data presented in Figures 12 could not readily validate the putative 
interaction of EspT and APPL1 in the given experimental setup. This subproject was therefore 
not followed up in the framework of this thesis. 
Figure 12: Pull-down assays to probe binding of EspT to APPL1.B16-F1 cells were transfected with GFP-APPL1 and 
lysed with ice-cold IP buffer. Lysates were incubated with recombinant proteins immobilized on Ni-NTA affinity resin. 
Samples were separated by SDS-PAGE and visualized by Western Blotting with anti-GFP antibody. Note that IP-Buffer „A“  
is a standard IP buffer as described in chapter 3.3.5; IP-Buffer „B“ is a ‘lipid friendly’ buffer lacking Triton-X-100 (cells 
lysed by ultrasound); IP-Buffer „C“ contains 1mM EDTA instead of 5mM MgCl2; IP-Buffer „D“ contains high 
concentration of salts (30 mM KCl and 150 mM NaCl) (chapter 3.3.5). Note that GFP-APPL1 was not bound by EspT in all 
four IP buffer conditions. 
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4.4 Bacterial virulence factor SifA and its predicted molecular target Cep70 
4.4.1 Subcellular localization of GFP-tagged Cep70 and co-localization studies of GFP-
Cep70 and Myc-SifA 
Based on the results of the Y2H screen, Cep70 was identified as a potential molecular target 
of the Salmonella bacterial virulence factor SifA. Recently, it was published that Cep70 
localizes to the centrosome throughout the cell cycle and interacts with γ-tubulin (Shi et al., 
2011). Its centrosomal localization was mediated via the coiled-coil domains (Shi et al., 
2011). Beside other functions, Cep70 has been reported to act as a regulator of microtubule 
assembly by promoting microtubule elongation rather than microtubule nucleation (Shi, 
2012). 
In order to learn more about the potential role of Cep70 in Salmonella infection, we first 
studied its subcellular localization in the presence and absence of SifA. Subcellular 
localization of GFP-tagged Cep70 was investigated by immunofluorescence microscopy in 
Cos-7 fibroblasts. In accordance with previously published data (Shi et al., 2011), analysis of 
immunofluorescence images in Cos-7 fibroblasts transiently transfected with GFP-Cep70 
confirmed that in most cases Cep70 localizes exactly at two centrosomes (Figure 13, top 
panel). However, in some cases I had observed a higher number of differently sized spots 
(Figure 13, middle panel) which might well correspond to the structures that were described 
as centriolar satellites (Tollenaere et al., 2015). 
Next, co-localization of GFP-Cep70 and Myc-SifA was further tested by 
immunofluorescence. Figure 13 shows corresponding images of fixed Cos-7 fibroblast cells 
overexpressing GFP-Cep70 with Myc-SifA. While SifA broadly distributed all over the cell, 
Cep70 signals were distinctly visible as discrete dots (Figure 13, bottom panel). Interestingly, 
at later stages of infection the Salmonella-containing vacuole (SCV) was positioned in close 
proximity to the microtubule-organizing center and, hence, centrosomes (Ramsden et al., 
2007). 
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Figure 13: Subcellular localization of GFP-tagged Cep70 and co-localization of Cep70 & SifA in Cos-7 fibroblasts. 
Cos-7 cells were transfected with the respective constructs, fixed 24 hours later with PFA and permeabilized. Nuclei were 
stained with DAPI. The actin cytoskeleton was stained with phalloidin as described in chapter 3.4.2. Merge shows an overlay 
of the green (GFP-Cep70), red (phalloidin and anti-Myc, respectively) and blue (Dapi) channel. Scale bars in full panels and 
the zoomed panel correspond to 10 μm and 1 μm, respectively. The insert of the marked region is enlarged 5 times.
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4.4.2 Cep70 is largely Triton X-100 insoluble 
Since I noticed a very poor expression of GFP-Cep70 in the Triton X-100 soluble fraction, I 
have analyzed the Triton X-100 solubility properties of this construct. For this, Hek293T cells 
were transiently transfected with GFP-Cep70 and subsequently analyzed by Western Blotting. 
I detected protein bands corresponding to the predicted molecular weight of 97 kDa. As 
shown in Figure 14, the Cep70 signal is mainly found in the Triton X-100 insoluble fraction 
of cell lysate. 
 
 
 
Therefore, biochemical analysis of the interaction between Cep70 and SifA in standard assays 
was hampered, since this centrosomal protein resides in a triton-insoluble fraction. In order to 
find out whether Cep70 plays a role during Salmonella infection, further studies should be 
carried out. It would be interesting to look if Cep70 influences SCV positioning close to the 
centrosome, for instance by Cep70 RNA interference (RNAi) in cell infected with 
Salmonella.  
Figure 14: Analysis of the Triton X-100 solubility of Cep70. Hek293T cells were 
transfected with GFP-Cep70 and lysed with ice-cold IP buffer “A” (chapter 3.3.5). Samples 
were applied to SDS-PAGE and analyzed by Western Blotting with anti-GFP antibody. 
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4.5 Bacterial virulence factor SifA and its predicted molecular target DYNLRB1 
4.5.1 Subcellular localization of DYNLRB1, SifA and Rab6a, and their co-localization 
studies 
Dynein Light Chain Roadblock type-1 protein (DYNLRB1), an 11 kDa protein has been 
reported to belong to the LC7/roadblock protein family. Dynein comprised of two heavy 
chains, two intermediate chains, four light intermediate chains and light chains of the 
LC7/roadblock, LC8 and Tctex1/rp3 protein families (Wanschers et al., 2008). As a 
multifunctional protein, DYNLRB1 has been involved in many cellular processes, such as 
cargo transport along microtubules, regulation of cell migration, cell division, maintenance of 
Golgi apparatus integrity, and transport of intracellular vesicles (Ashokkumar et al., 2009). 
It has recently been reported that DYNLRB1 specifically interacts and co-localizes with the 
small GTPase Rab6 in the Golgi (Wanschers et al., 2008).Furthermore, the cytoplasmic 
dynein interacted with N-acetylglucosamine kinase (GlcNAc kinase or NAGK), and this 
binding occurred on MT fibers at dendritic branch points (Islam et al., 2015). NAGK-
DYNLRB1 interaction played an essential role in dendritogenesis. Finally, DYNLRB1 has 
been reported to interact with human reduced folate carrier (Ashokkumar et al., 2009) and the 
transforming growth factor-β receptor complex (Tang et al., 2002). 
In order to probe the localization of GFP-DYNLRB1 subcellularly, Cos-7 cells were 
transfected with this construct. After fixation with PFA 24 hours post transfection, cells were 
permeabilized, treated with anti-Giantin antibody to visualize the Golgi, and stained with 
DAPI to visualize the cell nuclei. Immunofluorescence analyses in Cos-7 fibroblasts 
transiently transfected with GFP-DYNLRB1 revealed that this host proteinwas diffusely 
distributed throughout the cytoplasm. Represenative images have been depicted in Figure 15 
(top panel). 
Since Salmonella T3SS-2 effector SifA was identified as a potential interaction partner of the 
host protein DYNLRB1, I performed localization studies of the bacterial virulence protein 
SifA as well as co-localization studies of both proteins. Remarkably, the Salmonella virulence 
factor SifA was mostly distributed throughout the cytoplasm (Figure 15, bottom panel). When 
GFP-DYNLRB1 and Myc-SifA were co-expressed, I observed only a slight co-localization of 
both proteins in the area surrounding the Golgi (Figure 16, top panel). 
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Following the published findings from the group of Prof. Dr. Jack Fransen (Wanschers et al., 
2008), we aimed to extend this observation and questioned whether DYNLRB1 is recruited to 
the Golgi upon expression of active Rab6. At first, we investigated the subcellular localization 
of Rab6a and subsequently performed co-localization studies of GFP-DYNLRB1 and 
mCherry-Rab6a. Indeed, Rab6 alone localized to the Golgi structure (Figure 15, middle panel) 
and was moreover able to recruit DYNLRB1 to this site. Consequently, DYNLRB1 had not 
distributed within the cytoplasm any longer but distinctly localized to the Golgi together with 
Rab6 (Figure 16, upper middle panel) (Wanschers et al., 2008).  
Next, the interesting question arose whether the T3SS-2 effector SifA co-localizes with the 
GTPase Rab6 that is involved in microtubule-dependent transport pathways through the Golgi 
and from endosomes to the Golgi (Short et al., 2002). To answer this question, Cos-7 
fibroblasts were co-transfected with GFP-SifA and mCherry-Rab6a. I found that the small 
GTPase Rab6a can also force SifA to localize to Golgi-like structures (Figure 16, lower 
middle panel).  
Finally, I tested whether DYNLRB1 competes with Rab6 for SifA Golgi binding. For this 
purpose, Cos-7 fibroblasts were triple-transfected with GFP-DYNLRB1, mCherry-Rab6a and 
Myc-SifA. The results of this experiment clearly showed a compact co-localization of all 
three proteins in the Golgi region (Figure 16, bottom panel), suggesting that this triade does 
not show a competitive behavior. 
Taken together, the data presented in Figures 15 and 16 suggest that DYNLRB1 and SifA 
were diffusely distributed throughout the cytoplasm when expressed alone, whereas mCherry-
Rab6a was found exclusively in the Golgi (Figure 15). DYNLRB1 could be recruited to the 
Golgi by Rab6 (Figure 16, upper middle panel), which was in accordance with previously 
published data (Wanschers et al., 2008). Similarly, Rab6 could recruit SifA to Golgi-like 
structures (Figure 16, lower middle panel). Finally, co-expression of all three proteins resulted 
in significant co-localization in the Golgi region (Figure 16, bottom panel). As Rab6 was the 
master regulator of DYNLRB1 and SifA localization, we tested whether SifA might also 
interact with Rab6, assuming that the binding was mediated by its GEF-like domain (see 
below Figure 18).  
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Figure 15: Subcellular localization of GFP-DYNLRB1, GFP-SifA and mCherry-Rab6a. Cos-7 cells were transfected 
with respective constructs, fixed 24 hours later with PFA and permeabilized. Nuclei were stained with DAPI. Golgi was 
stained with anti-Giantin rabbit polyclonal antibody as described in chapter 3.4.2. The scale bar indicates 10 μm. 
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Figure 16: Co-localization studies of DYNLRB1 & SifA (top panel); DYNLRB1 & Rab6a (upper middle panel); SifA 
& Rab6a (lower middle panel) and DYNLRB1 & SifA & Rab6a (bottom panel). Cos-7 cells were transfected with 
respective constructs, fixed 24 hours later with PFA and permeabilized. Nuclei were stained with DAPI (blue in merge). 
Myc-tagged SifA protein was labeled with mouse anti-Myc antibody (red in merge). The scale bar is 10 μm. 
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4.5.2 Biochemical analysis of the interaction of DYNLRB1 with SifA 
The potential interaction between the host protein DYNLRB1 and the bacterial virulence 
protein SifA was further scrutinized in vitro, as described in chapter 3.3.5. Purified 
recombinant His-MBP-SifA ∆ext and GFP-DYNLRB1 were used in a pull-down assay as 
bait, and prey, respectively. As a negative control I used His-MBP in the experiments. The 
results of these experiments have been shown in Figure 17. 
 
 
 
 
 
 
 
 
 
 
 
As expected, I detected a band of approximately 38 kDa, corresponding to the predicted 
molecular weight of GFP-DYNLRB1, when using a monoclonal antibody against GFP. There 
were strong signals in the load controls and supernatant after pull-down. In the pull-down 
lanes corresponding to His-MBP no bands could be observed. The same results were obtained 
when buffers with different salt concentrations were used. Only under conditions where 
membrane lipids were present (B) or when the water activity was reduced due to high salt (D), 
a weak interaction of His-MBP-SifA ∆ext and GFP-DYNLRB1 was detected. 
Since immunofluorescence analysis clearly illustrated co-localization of all three proteins, 
DYNLRB1, SifA and Rab6a, in the Golgi region, we hypothesized that DYNLRB1 might 
interact with SifA more strongly or even only in the presence of small GTPase Rab6a. In 
order to explore the putative interaction of DYNLRB1 and SifA and its potential dependence 
Figure 17: Pull-down assays to probe binding of SifA to DYNLRB1. B16-F1 cells were transfected with GFP-
DYNLRB1, lysed with ice-cold IP buffer and the lysates were incubated with recombinant proteins immobilized on Ni-NTA 
beads. Samples were analyzed by SDS-PAGE and Western Blotting using anti-GFP antibody. Note that IP-Buffer „A“ is a 
standard IP buffer as described in chapter 3.3.5; IP-Buffer „B“ is a ‘lipid friendly’ buffer lacking Triton (cells lysed by 
ultrasound); IP-Buffer „C“ contains 1mM EDTA instead of 5mM MgCl2; IP-Buffer „D“ contains high concentration of salts 
(30 mM KCl and 150 mM NaCl) (chapter 3.3.5). DYNLRB1 only weakly bound to SifA in 2 of 4 different IP buffer 
conditions. 
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on Rab6a, we repeated our analysis using Hek293T cells co-transfected with the GFP-
DYNLRB1 and the mCherry-Rab6a constructs. Using these lysates, we performed pull-down 
assays with recombinant His-MBP-SifA ∆ext as bait. His-MBP-SifB ∆ext and His-MBP-
EspT were used as controls. Representative results of the biochemical analyses have been 
illustrated in Figure 18. 
 
 
 
 
 
 
 
 
 
 
 
These co-precipitation experiments revealed that small GTPase Rab6 does not directly 
interact with WxxxE family members such asSifA and SifB of Salmonella, and EspT from 
EPEC and C. rodentium. Moreover, the biochemical data suggested that Rab6a-DYNLRB1 
complexes (Wanschers et al., 2008) do not bind SifA under these conditions. 
In summary, I was not able to observe any notable differences in the pull-down assays (Figure 
18, B) as compared to previous experiments (Figure 17). Unfortunately, these results could 
not confirm my hypothesis that Rab6a has an influence on the interaction between host 
DYNLRB1 and bacterial SifA proteins. 
In conclusion, the data presented in Figures 17 and 18 indicated that interaction between 
DYNLRB1 and SifA couldnot unequivocally be demonstrated using this technique. However, 
the co-localization data and the results of Y2H screening strongly argued for this interaction. 
In addition, interaction studies have shown that SifA does not directly bind to Rab6.  
Nevertheless, co-expression of Rab6 and SifA led to a significant recruitment of SifA to the 
Golgi. A better understanding of this dynamic co-localization would require further 
experiments that were beyond the scope of this thesis. 
Figure 18: Pull-down assays to probe binding of SifA to DYNLRB1 in the presence of Rab6a. Hek293T cells were 
transfected with mCherry-Rab6a alone or co-transfected with GFP-DYNLRB1, lysed with ice-cold IP buffer and the lysates 
were incubated with immobilized recombinant proteins (chapter 3.3.5). Samples were analyzed by SDS-PAGE and 
visualized by Western Blotting with anti-RFP and anti-GFP antibodies. Note that Rab6a was not bound to SifA (A) and that 
in the presence of Rab6a, DYNLRB1 was not bound to SifA under these conditions (B). 
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4.6 Bacterial virulence factor SifA and Rab9 
4.6.1 Biochemical analysis of the interaction of SifA with Rab9 
During parallel studies in our lab it was discovered that among all members of Rab GTPases 
family, only Rab9 interacts with SifA (e.g. PhD Thesis of S. Arens). It has been found that up 
to 18 Rabs were present on the SCV during its maturation (Brumell & Scidmore, 2007). 
Recent evidence highlighted a new function of Rabs, namely that Rab9 and Rab7 regulate 
membrane trafficking processes at the late endosome-lysosome system. One of the most 
interesting features of both Rabs was that Rab7 and Rab9 were shown to be essential for SIFs 
formation (Smith et al., 2007; Brumell & Scidmore, 2007). This finding made Rab9 a highly 
interesting candidate for our research. Aiming to confirm interaction between SifA and Rab9, 
we transfected Hek293T cells with mCherry-Rab9 and performed pull-down assay. Purified 
recombinant His-MBP-SifA ∆ext and mCherry-Rab9 were used as bait and prey, respectively. 
His-MBP, His-MBP-SifB ∆ext and His-MBP-EspT were used as controls. The experimental 
results have been shown in Figure 19. 
 
 
 
 
 
 
 
 
 
As shown in Figure 19, I observed both Rab9 and SifA in the pull-down sample probed with 
an anti-RFP antibody, which confirmed a weak interaction between these proteins. However, 
additional studies would be required to explore the molecular mechanisms underlying this 
interaction. Nonetheless, these experiments further corroborated that the lack of SifA binding 
to Rab6 was specific. 
Figure 19: Pull-down assays to probe binding of SifA toRab9. Hek293T cells were transfected with mCherry-Rab9, 
lysed with ice-cold IP buffer and the lysates were incubated with immobilized recombinant proteins. Samples were analyzed 
by SDS-PAGE and visualized by Western Blotting with anti-RFP antibody as described in chapter 3.3.5. Note that Rab9 
interacts with SifA. 
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4.6.2 Biochemical analysis of the potential interaction between DYNLRB1 and SifA in 
the presence of Rab9 
Due to the fact that Rab9 interacted with SifA, as shown above by the pull-down assays, I 
raised the hypothesis that Rab9 may affect interaction between DYNLRB1 and SifA. For that, 
I co-transfected Hek293T cells with GFP-DYNLRB1 and mCherry-Rab9 and used 
recombinantly expressed His-MBP-SifA ∆ext as bait in pull down assays, His-MBP, His-
MBP-SifB ∆ext and His-MBP-EspT were used as negative controls. Representative results of 
the biochemical analysis have been illustrated in Figure 20. 
 
 
 
 
 
 
 
 
Western blot analyses using an anti-GFP antibody showed that GFP-DYNLRB1 was not 
detected in the pellet after pulling down with recombinant SifA (Figure 20 A). I however 
detected a band of approximately 55 kDa, corresponding to mCherry-Rab9, in the pellet after 
incubation with SifA (Figure 20 B). I observed traces of the protein in the respective pull 
down samples of SifB and EspT, but still, the signal was much less than in pull down samples 
of SifA. These experiments suggested that the presence of Rab9 does not mediate an 
interaction between DYNLRB1 and SifA, but confirms the binding of SifA ∆ext to Rab9 (see 
Figure 19). 
Figure 20: Pull-down assays to probe binding of SifA to DYNLRB1 in the presence of Rab9. Hek293T cells were co-
transfected with GFP-DYNLRB1 and mCherry-Rab9 constructs; the cells were lysed with ice-cold IP buffer and the lysates 
were incubated with recombinant proteins as described in chapter 3.3.5. Samples were analyzed by SDS-PAGE and 
visualized by Western Blotting with anti-GFP (A) and anti-RFP antibodies (B). Note that Rab9 but not DYNLRB1 binds to 
SifA ∆ext. 
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4.6.3 Subcellular localization of mCherry-tagged Rab9 and co-localization studies of this 
GTPase with DYNLRB1, SifA and these two proteins together. 
In order to compare this influence of co-expression of Rab9 together with either DYNLRB1 
or SifA alone of both proteins together, I initially performed localization analysis of mCherry-
Rab9 in Cos-7 cells. This GTPase predominantly localized in the Golgi region (Figure 21, top 
panel), as visualized by a high degree of mCherry-Rab9 co-localizing with Giantin, a marker 
for the Golgi, reminiscent of Rab6 (Figure 15, middle panel). 
To address whether the Rab9-like Rab6a recruited DYNLRB1 to the Golgi region, we 
performed co-localization studies in Cos-7 fibroblasts transiently transfected with GFP-
DYNLRB1 and mCherry-Rab9 (Figure 21, upper middle panel). GFP-DYNLRB1 appeared to 
localize mainly in the cytoplasm, both in presence and in absence of ectopically expressed 
Rab9. Results of these experiments indicated that both proteins, although they partially 
overlap in the Golgi region, do not co-localize in a manner comparable to that of Rab6 and 
DYNLRB1 (Figure 21, upper middle panel).  
Since I noticed the biochemical interaction of Rab9 with SifA, I was prompted to analyze 
whether Rab9 could affect the localization of SifA. While SifA overexpression alone in the 
Golgi, co-expression of Myc-SifA and mCherry-Rab9 led to the co-localization of both 
proteins at the Golgi (Figure 21, lower middle panel), indicating that Rab9 could effect SifA 
localization. 
Finally, I investigated the effect of Rab9 on the co-localization of DYNLRB1 and SifA. For 
this purpose, Cos-7 fibroblasts were triple-transfected with GFP-DYNLRB1, mCherry-Rab9 
and Myc-SifA (Figure 21, bottom panel). Noteworthy, DYNLRB1 was co-recruited together 
with SifA to the Golgi by Rab9, but not alone. This indicated that Rab9 couldnot recruit 
DYNRB1 directly, but rather via SifA. This was in contrast to Rab6, which recruits 
DYNLRB1 directly in the absence of SifA. 
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Figure 21: Subcellular localization of mCherry-tagged Rab9 and co-localization studies of this GTPase with 
DYNLRB1, SifA and these two proteins together. Cos-7 cells were transfected with respective constructs and fixed 24 
hours later with PFA. Nuclei were stained with DAPI (blue). The Golgi was stained with anti-Giantin rabbit polyclonal 
antibody and is shown in green. The Myc tag was labeled with a mouse anti-Myc antibody. As secondary antibodies, anti-
mouse Alexa Fluor® 350, Alexa Fluor® 488, were used, respectively (chapter 3.4.2). The scale bar indicates 10 μm. Note 
that SifA is recruited to the Golgi region by Rab9. 
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4.7 Bacterial virulence factor SifB and its predicted molecular target CLIP4 
4.7.1 Subcellular localization of GFP-tagged CLIP4 
CLIP4 was a not yet characterized protein of so far unknown function that harbors Ankyrin-
repeats (ANK) and cytoskeleton-associated protein-glycine-rich (CAP-Gly)-domains. CLIP4 
belonged to the CAP-GLY Domain Containing Linker Proteins (CLIP) family, which 
comprises four members (Figure 22 A). The first identified member of this family was CLIP 
170 (cytoplasmic linker protein of 170 kDa), also termed CLIP1. CLIP1 and CLIP2, also 
referred to as CLIP115, have been  the most investigated proteins of this family and have been 
also known as MT-tip binding proteins (Perez et al., 1999). 
(A) 
(B) 
 
 
 
 
 
 
 
Figure 22: Schematic domain overview of CAP-Gly proteins and CLIP4-constructs. (A) Schematic representation of the 
CAP-Gly family of proteins with the conserved domains. These proteins share CAP-Gly domains, which in the case of 
CLIP1 and CLIP2 localize to microtubule plus ends. In addition, CLIP1 contains EEY/F motif, which binds to the end-
binding proteins (EB) (Gupta et al., 2010). In contrast to CLIP1, CLIP2 lacks the zinc finger domain (ZnF) and thus does not 
bind to the dynein-dynactin complex (Steinmetz et al., 2008). Beside CAP-Gly domains, CLIP3 and CLIP4 harbor Ankyrin 
repeat (ANK) domain consisting of two α-helices separated by loops. Whereas most CAP-Gly proteins bind to MTs, CLIP3 
localizes to the trans-Golgi by a palmitoylation membrane-targeting motif enclosed within the last 30 amino acids (PMT) 
(Lallemand-Breitenbach et al., 2004; Perez et al., 2002). (B) Schematic representation of full-length and truncated versions of 
CLIP4 protein used for immunofluorescence and pull down assays. CLIP4-∆ANK is a construct lacking ANK-repeats 
domain on the N-terminal region of the full-length CLIP4. CLIP4-∆CAP-Gly is a construct lacking CAP-Gly and basic serine 
domains on the C-terminal region of the full-length CLIP4. Abbreviations: ANK, ankyrin repeats; E/P, glutamate-proline 
rich; PMT, palmitoylation membrane-targeting motif; ZnF, zinc finger domain. 
Results 
 
65 
 
Since CLIP4 was likely associated with the cellular microtubule system and since SIFs spread 
through the cell by using MTs, we decided to put effort into analyzing this hit from our Y2H 
screen. 
To investigate the cellular function of CLIP4, I studied its subcellular localization. For that, 
Cos-7 fibroblasts were fixed 24 hours post transfection with GFP-CLIP4 and labeled with 
antibodies against tubulin (Figure 23, top panel). The subcellular distribution of CLIP4 
strongly overlapped with MTs in transiently transfected Cos-7 fibroblasts. These results 
suggested that CLIP4 was a microtubule-binding protein (Figure 23, top panel) rather than a 
MT-Tip protein. In order to identify the domains needed for microtubule localization, we 
generated various truncated forms of CLIP4 protein tagged with GFP (Figure 22 B).  
Hence, I tested individually the localization of the N-terminal Ankyrin-repeats and the C-
terminal CAP-Gly-domains of CLIP4 protein. The construct lacking the ANK-repeats but 
harboring the CAP-Gly domains displayed characteristic microtubule localization (Figure 23, 
middle panel). In contrast, a construct lacking the CAP-Gly domains could not decorate 
microtubules and appeared cytoplasmic (Figure 23, low panel). This led us to the conclusion 
that localization of CLIP4 to MTs was mediated by the CAP-Gly domains and not the 
Ankyrin repeats (Figure 23). 
Taken together, the data presented in Figures 23 indicate that the microtubule localization of 
CLIP4 depended on its CAP-Gly domains (C-terminal region), which are similar to those of 
CLIP 170 and CLIP 115.  
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Figure 23: Subcellular localization of GFP-tagged CLIP4 and localization of truncated constructs lacking the N-
terminal ANK-repeats and the C-terminal CAP-Gly-domains, respectively in Cos-7 fibroblasts. Cos-7 cells were 
transfected with respective GFP-tagged constructs of CLIP4, fixed 24 hours later with PFA and permeabilized. Nuclei were 
stained with DAPI. Staining of the transfected cells with anti-tubulin (YL ½) antibody revealed that CLIP4 is a microtubule-
binding protein. The overlay shows the respective GFP-construct in green, Tubulin in red and Dapi in blue. The scale bar 
indicates 10 μm. 
Results 
 
67 
 
4.7.2 Time-lapse imaging of GFP-labelled CLIP4 
In addition to immunostaining experiments of fixed cells, I studied the behavior of transfected 
GFP-CLIP4 cells using time-lapse fluorescence microscopy. This approach allowed 
visualization of the dynamic localization of CLIP4 on MTs. For this purpose, Cos-7 
fibroblasts were transfected with GFP-tagged CLIP4 and fluorescent signals were recorded 
over time as described in chapter 3.4.2.5. During time-lapse acquisition, I monitored 
movement patterns within individual GFP-CLIP4 transfected cells. I made the observation 
that many cells died during the first hours. Nevertheless, I succeeded to record the dynamics 
of CLIP4, the fourth member of the CAP-Gly family. Representative images have been shown 
in Figure 24. Live cell imaging confirmed our previous assumption that CLIP4 is a 
microtubule-binding protein.  
 
Figure 24: Time-lapse imaging of dynamic of microtubule protein CLIP4. Cos-7 cells were transfected with GFP-tagged 
CLIP4 construct and seeded onto Ø35 mm glass bottom µ-dishes (Ibidi) covered with fibronectin. Dynamics of CLIP 4 
protein was visualized at Nikon BioStation IM (40X magnification) over 8 hours in 5 min intervals. The scale bar indicates 
10 μm. The images were extracted from the supplementary movie 1. Time (h:min) is indicated in the upper left corner of each 
image. 
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4.7.3 Biochemical analysis of the potential interaction between CLIP4 and SifB 
Based on Y2H screening results, I commenced to investigate the potential interaction between 
the host protein CLIP4 and the bacterial virulence protein SifB. For this, I performed pull-
down assays, as described above, with Hek293T cells transiently transfected with GFP-tagged 
CLIP4. Purified recombinant His-MBP-SifA ∆ext and His-MBP-SifB∆ext were used as baits, 
and expressed GFP-CLIP4 protein served as prey. As a negative control for our experiment, 
we used His-MBP and His-MBP-EspT. Representative results of biochemical analysis have 
been given in Figure 25. 
 
 
 
 
 
GFP alone, which served as a negative control, did not bind either SifA or SifB in all 
experiments performed (Figure 25 A). In contrast, I detected GFP-CLIP4 of the expected 
molecular weight (103 kDa) in the pellet where SifB ∆ ext was used as bait. Therefore, this 
assay confirmed a positive interaction between CLIP4 and SifB, but not SifA (Figure 25 B), 
which has been in line with our Y2H result. 
 
4.7.4 Mapping the interaction surface of SifB and CLIP4 
In order to gain detailed knowledge about the interaction surfaces of the two proteins, I 
generated various truncated forms of human CLIP4 tagged with GFP, and performed pull-
down assays as described above. As previously mentioned, the purified recombinant His-
MBP-SifA ∆ext and His-MBP-SifB ∆ext were used as baits while the ectopically expressed 
GFP-CLIP4 protein was used as prey. As negative controls, I used His-MBP and His-MBP-
EspT.  
 
Figure 25: Pull-down assays to probe binding of SifB to CLIP4. Hek293T cells were transfected with GFP or GFP-
CLIP4 constructs, lysed with ice-cold IP buffer and the lysates were incubated with recombinant proteins as described in 
chapter 3.3.5. Samples were analyzed by SDS-PAGE and visualized by Western Blotting with anti-GFP antibody. (A) Note 
that GFP alone was not bound by either SifA or SifB. (B) Note that GFP-CLIP4 readily bound to SifB, but not to SifA. 
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In summary, the above assays confirmed that SifB readily binded to CLIP4; this binding 
depended on the C-terminus of CLIP4 that harbored the CAP-Gly-domains (Figure 26 A) but 
not the N-terminal ANK repeats (Figure 26 B). 
In order to confirm that the CAP-Gly domain region of CLIP4 was essential for the 
interaction with SifB, different deletion mutants of the C-terminal part of the full-length 
CLIP4 were tested in a subsequent pull-down assay. 
 
 
 
 
 
 
The data showed that the region of CLIP4, which enclosed the 2
nd
 and 3
rd
 CAP-Gly domain 
and a basic serine region in between them at its C-terminal part, was necessary and sufficient 
for the interaction with SifB (Figure 27 D). An overview of the used domain constructs along 
with the results has been depicted in Figure 28.  
Figure 26: Pull-down assays of SifB and C-terminal CAP-Gly-domains or an N-terminal ANK-repeats of CLIP4. 
Hek293T cells were transfected with respective GFP-tagged constructs of CLIP4, lysed with ice-cold IP buffer and the 
lysates were incubated with recombinant proteins as described in chapter 3.3.5. Samples were analyzed by SDS-PAGE and 
visualized by Western Blotting with anti-GFP antibody. (A) Note that construct lacking the ANK repeats domains of GFP-
CLIP4 binds SifB. (B) Note that construct lacking the CAP-Gly domains of GFP-CLIP4 does not bind SifB. 
Figure 27: Pull-down assays of SifB and C-terminally truncated CLIP4 mutants. Hek293T cells were transfected with 
various truncated forms of GFP-CLIP4 constructs, lysed with ice-cold IP buffer and the lysates were incubated with 
recombinant proteins as described in chapter 3.3.5. Samples were analyzed by SDS-PAGE and visualized by Western 
Blotting with anti-GFP antibody. Note that constructs comprising the 1st CAP-Gly domain alone (A) or the 1st and 2nd 
CAP-Gly domain of CLIP4 (B) did not bind to SifB ∆ext, whereas a construct comprising the C-terminal 2nd and 3rd CAP-
Gly domains significantly bound to SifB ∆ext. 
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Taken together, these results supported the idea that the full-length CLIP4 protein specifically 
interacted with the WxxxE domain of SifB (SifB∆ext), but not with SifA (Figure 25 B). 
Furthermore, these experiments demonstrated that SifB-binding depended on the C-terminal 
CAP-Gly-domains (Figure 26 A), whereas no binding could be detected by either the N-
terminal ANK-repeats (Figure 26 B) or the 1
st
 CAP-Gly domain (Figure 4.18 A). Noteworthy, 
the 2
nd
 and 3
rd
 CAP-Gly domains also surrounded a central basic region which was apparently 
required in addition to the CAP-Gly domains (Figure 27 D). 
Figure 28 illustrates the results of mapping of the interaction surface of CLIP4 and SifB. 
 
 
 
 
 
 
 
 
Figure 28: Schematic summary of protein-protein interaction mapping. 
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4.7.5 Subcellular localization of GFP-tagged CLIP3 
The closest relative of CLIP4 within the CLIP protein family is CLIP3, also known as 
CLIPR-59 (Lallemand-Breitenbach et al., 2004). CLIP3 had been identified as a neuronal 
specific protein. Recent studies indicated that CLIP3 (CLIPR-59) interacted with the kinase 
domain of Akt via its first CAP-Gly domain (Ding et al., 2009). CLIP3 has been reported to 
regulate the membrane localization of Akt. In contrast to the other CLIP family members, the 
third member of the CAP-Gly family, CLIP3, localized to the trans-Golgi region and was 
involved in the early/recycling endosome–TGN transport pathway (Perez et al., 2002). 
In order to investigate whether the interaction of SifB was specific to CLIP4 or also occured 
with CLIP3, we used full-length wild-type and mutant constructs of human CLIP3, a courtesy 
of Franck Perez (Institut Curie, Paris). 
 
Figure 29: Schematic domain overview of CLIP3 protein. Abbreviations: ANK, ankyrin repeats; E/P, glutamate-proline 
rich; PMT, palmitoylation membrane-targeting motif. 
In order to analyze intracellular localization of CLIP3 in our experimental system, Cos-7 
fibroblasts were transiently transfected with respective GFP-tagged constructs of CLIP3, fixed 
24 hours post transfection and labeled with antibodies to stain the Golgi apparatus. 
As expected, we observed that ectopically overexpressed GFP-CLIP3 co-localized at the 
Golgi complex as visualized by the marker Giantin (Figure 30, top panel). In contrast to the 
wild-type CLIP3 protein, the localization pattern of CLIP3 mutated in two amino acid 
residues, C534A and C535A, was cytoplasmic (Figure 30, bottom panel). These results were 
in agreement with the previously published data (Perez et al., 2002).This showed that the 
CAP-Gly domain of CLIP3 possesses no independent MT-binding activity. 
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Figure 30: GFP-CLIP3 localizes to the Golgi apparatus and trans-Golgi via its C-terminal isoprenylation motif (PTM 
domain). Cos-7 cells were transfected with CLIP3 and its mutation form and fixed 24 hours later with PFA (chapter 3.4.2). 
Nuclei were stained with DAPI. Golgi was stained with anti-Giantin rabbit polyclonal antibody. The overlay shows the 
respective GFP-construct in green, Giantin in red and Dapi in blue. The scale bar indicates 10 μm. Note that the construct 
lacking the C-terminal isoprenylation motif (PTM domain) lost the ability to target to the Golgi region. 
 
4.7.6 Biochemical analysis of the potential interaction between CLIP3 and SifB 
In the next step, I investigated whether an interaction between CLIP4 and SifB is specific or 
whether other CAP-Gly proteins might also interact with SifB. First, I assessed the interaction 
between CLIP3, the closest relative of CLIP4, and SifB in a pull-down assay, as described 
above. Similarly to the previous pull-down assays, the purified recombinant His-MBP-EspT, 
His-MBP-SifA ∆ext and His-MBP-SifB ∆ext served as baits whereas the ectopically 
expressed GFP-CLIP3 protein served as prey. As a negative control, we used His-MBP. The 
results of the biochemical analyses are shown in Figure 31. 
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At this point, it is not clear whether the interaction between CLIP3 and the bacterial factors is 
plausible. In order to minimize false-positive results, ice-cold IP wash buffer containing 1% 
Triton X-100 (chapter 3.3.5) was supplemented with various concentrations (10-60 mM) of 
imidazole.  
 
 
 
 
 
 
 
The data obtained in these experiments indicate that CLIP3 was not bound to SifA, SifB and 
EspT (Figure 32), as increasing concentration of imidazole in the wash buffer reduced 
nonspecific binding. Finally, it was found that CLIP3 is highly expressed in adipose tissue 
and brain (Ding et al., 2009). Therefore, we considered that CLIP3 unlikely plays a significant 
role in Salmonella infection, and excluded a potential involvement of the third member of 
CAP-Gly family in this process. 
Figure 31: Pull-down assays to probe binding of SifB to CLIP3. Hek293T cells were transfected with wild type and 
mutant GFP-CLIP3 constructs, lysed with ice-cold IP buffer and the lysates were incubated with recombinant proteins. 
Samples were analyzed by SDS-PAGE and visualized by Western Blotting with anti-GFP antibody. Note that GFP-CLIP3 
(WT) is largely insoluble and in addition occurs in the pull-downs of both SifA and SifB. 
Figure 32: Pull-down assays to probe binding of SifB to CLIP3 in the presence of imidazole. Hek293T cells were 
transfected with GFP-CLIP3 construct, lysed with ice-cold IP buffer and the lysates were incubated with recombinant 
proteins. Samples were analyzed by SDS-PAGE and visualized by Western Blotting with anti-GFP antibody. Note lack of 
binding of CLIP3 to the respective bait with increasing imidazole concentration. 
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4.7.7 Biochemical analysis of the potential interaction between CLIP1-2 and SifB 
CLIP1 (170) and CLIP2 (115) have been known as microtubule (MT)-Tip proteins. Both 
GFP-CLIP1-FL and GFP-CLIP2-FL localized to microtubule plus ends, a feature referred to 
as “plus-end tracking” (“+TIPs”) (Akhmanova & Steinmetz., 2010; Akhmanova & 
Steinmetz., 2008; Galjart, 2005). Since CLIP4 binded to SifB via its CAP-Gly domains, and 
since this feature might be conserved in CLIP3 (see 4.7.6), I aimed at investigating whether 
the CAP-Gly domains of CLIP1 and CLIP2 had any affinity for SifB. To probe for the 
binding, I used the isolated CAP-Gly domains of CLIP1 (CLIP170) and CLIP2 (CLIP115), a 
courtesy of Dr. Marco Van Ham (HZI, Braunschweig). In Figure 33, the domain structures of 
mutant CLIP1 and CLIP2 have been presented.  
 
Figure 33: Schematic representation of truncated CLIP1 and CLIP2 constructs used for pull-down assays. 
The potential interaction between the bacterial virulence protein SifA/B and the host protein 
CLIP1 or CLIP2 was further studied in the pull-down assays as described in chapter 3.3.5. 
Purified recombinant His-MBP-SifA ∆ext and His-MBP-SifB ∆ext were used as baits, and 
expressed GFP-CLIP1 or GFP-CLIP2 protein served as prey. As a negative control for our 
experiment, we used His-MBP and His-MBP-EspT.Representative results of the biochemical 
analysis have been illustrated in Figure 34. 
 
 
 
 
 
Figure 34: Pull-down assays to probe for binding of SifB to CLIP1 and CLIP2. Hek293T cells were transfected with 
GFP-CLIP1 or GFP-CLIP2 constructs, lysed with ice-cold IP buffer, and the lysates were incubated with recombinant 
proteins as described in chapter 3.3.5. Samples were analyzed by SDS-PAGE and visualized by Western Blotting with anti-
GFP antibody. Note that neither GFP-CLIP1 nor GFP-CLIP2 bound by SifB. 
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Therefore, these results indicated that His-MBP-tagged SifB did not interact with +TIPs, such 
as GFP-tagged CLIP1 or CLIP2 (Figure 34). 
In summary, the results presented in this section suggest that the bacterial virulence factor 
SifB specifically interacts with the fourth member of CAP-Gly family (CLIP4), but does not 
interact with other members of this family, although they share significant sequence 
similarities including common CAP-Gly domains, connected by a basic serine stretch. 
 
4.7.8 Expression profile of CLIP4 in primary human and mouse tissues 
To gain more insights into the expression pattern of CLIP4 I have searched in the NCBI GEO 
database (http://www.ncbi.nlm.nih.gov/geo/). The data were complemented with those from 
the human Protein Atlas (http://www.proteinatlas.org/). High expression of endogenous 
CLIP4 was observed in smooth, skeletal and heart muscles, bone marrow and some inner 
organs including the gut, whereas no expression was observed e.g. in thyroid gland, spleen 
and liver (Figure 35). 
 
Figure 35: Expression of CLIP4 in primary human tissues. Data were extracted from the human Protein Atlas resource. 
According to the NCBI database and Ensembl genome browser, there have been four splice 
variants of CLIP4 reported in mice (Table 39). 
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Table 39: Mouse CLIP4 splice variants 
Splice variants Amino Acids  Molecular weight 
CLIP4-isoform 1 704 76 kDa 
CLIP4-isoform 2 551 59 kDa 
CLIP4-isoform 3 694 75 kDa 
CLIP4-isoform 4 598 64 kDa 
 
Next, I asked where CLIP4 protein might be expressed in primary mouse tissues. To answer 
this question, I analyzed protein expression of CLIP4 in murine tissue lysates by Western 
blotting using a polyclonal antibody against CLIP4 and compared it to that in human tissues. 
Isolation of primary mouse tissues was performed by Stephanie Stahnke (HZI, Braunschweig) 
as described in the chapter 3.7. It should be noted that splice variants of a significantly 
reduced size were present in the muscle, but not depicted on the gel below. 
 
Figure 36: Expression pattern of CLIP4 in primary mouse tissues visualized on Western blot. Lysates of mouse tissue 
samples were mixed with 4x SDS sample buffer, subjected to SDS-PAGE and the endogenous level of CLIP4 was detected 
by Western blotting using polyclonal anti-CLIP4 antibody. The expected molecular weight of long form of CLIP4 is 76 kDa 
I observed that the CLIP4 protein was expressed in stomach, spleen and small intestine. In 
addition, a slightly smaller band was observed in lung and kidney that might likely correspond 
to a CLIP4 splice variant. Note that all bands detected in tissues might not correspond to the 
longest splice variant, because the latter showed an apparent molecular weight of 76 kDa 
(compare Figure 38). In other tissues, expression of the long variant of CLIP4 was either 
absent or close to the detection limit of Western blotting. CLIP4 in heart and skeletal muscle 
most likely corresponded to the short variants (personal communication with Prof. Dr. Holly 
Goodson) and the specific antibody used here could not detect it. 
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4.7.9 Characterization of CLIP4 protein expression in different cell types. 
Next, we compared the mRNA expression profile of CLIP4 to that of other members of CAP-
Gly family in different cell lines. For that, we analyzed the datasets from Gene Chip analysis 
that were obtained in earlier projects.  
 
 
 
 
 
 
 
Significant differences of CLIP4 expression levels were observed between cell lines: a 
relatively high and an average amount of RNA in A431 and VA13, respectively, and its virtual 
absence in the other lines tested, such as HeLaS3, CaCo2, B16-F1, NIH3T3 and Swiss3T3. It 
would be worth to mention that the expression of CLIP4 in A431 cells was even higher than 
that of the abundant CLIP1, which was set to the arbitrary level 1 for comparability. Analysis 
of CLIP2-4 expression profiles indicated that these proteins had similar expression levels in 
HeLaS3 and CaCo2 cells. I also observed that CLIP3, which was the closest relative to 
CLIP4, was expressed (8 times more than CLIP4) in the Swiss cell lines. In conclusion, the 
data suggested that CLIP4 RNA was absent in virtually every cell line studied, except A431 
and VA13 cell lines. Next, the protein expression of the endogenous CLIP4 protein was 
analyzed in human and mouse cell lines using Western blotting. For that, Hek293T cells were 
transfected with untagged CLIP4, which served as control for the determination of the 
apparent molecular weight in SDS-PAGE. 
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Figure 37: Expression levels of CLIP2-4 normalized to CLIP1 assessed by microarray analyses of different cell lines. 
Note high expression of CLIP4 mRNA levels in A431. 
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Figure 38: Western blotting analysis of CLIP4 protein expression in human and mouse tissues. Cells were lysed with 
4x SDS buffer, the lysates were applied to SDS-PAGE and the proteins were visualized by Western blotting using polyclonal 
anti-CLIP4 antibody. Hek293T cells transfected with untagged CLIP4 served as control. 
Expression of CLIP4 was hardly detectable in almost all cell lines. In accordance with 
GeneChip analyses, mRNA of CLIP4 was absent in Hek293 and NIH3T3 cells. However, the 
CLIP4 protein was weakly expressed in A431 cells as a weak signal corresponding to the 
predicted molecular weight of CLIP4 (76 kDa) could be observed. The presence of additional 
bands indicated non-specific binding of polyclonal antibodies to the membrane because these 
bands were equally present in cells lacking CLIP4 RNA and, hence, the protein. We could not 
exclude that the band at ~59 kDa corresponded to a smaller splice variant. 
It would be worth mentioning that the expression of endogenous CLIP4 protein was found 
predominantly in tissues that contain mainly quiescent or postmitotic cells (GEO database), 
but not in constantly dividing cells such as continuously cultivated tissue cells, where the 
amount of CLIP4 was about the detection limit of Western blot analysis or absent (see Figure 
37 and 38). 
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4.7.10 Generation of human CLIP4 knockout cell lines using CRISPR/Cas9 Genome 
Engineering Tool 
Since nothing was known about the biological function of the fourth member of CAP-Gly 
family (CLIP4), we aimed to address this question using the CRISPR/Cas9 system, which 
allowed to knock out a gene of interest in any cell lines. For this purpose, we employed A431 
cell lines using this powerful and elegant technique. We generated several constructs of 
pSpCas9 (BB)-2A-GFP which harbors sgRNAs targeting CLIP4, as described in chapter 3.6. 
Representative sequencing results of a plasmid DNA comprising guide sequences have been 
demonstrated in Figure 39. 
 
pSpCas9 (BB)-2A-GFP containing sgRNA targeting CLIP4 (exon 2) 
AAAGGACGAAACACCGTCCTGGCATGATGCATCATTGTTTTAGAGCTTTTCCTGC
TTTGTGGCAGGACCGTACTACGTAGTAACAAAATCTCGA 
 
pSpCas9 (BB)-2A-GFP containing sgRNA targeting CLIP4 (exon 4) 
AAAGGACGAAACACCGACATTAGTTTGCGGAGTCGCGTTTTAGAGCTTTTCCTGC
TTTGTGGCTGTAATCAAACGCCTCAGCGCAAAATCTCGA 
 
WT pSpCas9 (BB)-2A-GFP  
AAAGGACGAAACACCGGGTCTTCGAGAAGACCTGTTTTAGAGCT 
TTTCCTGCTTTGTGGCCCAGAAGCTCTTCTGGACAAAATCTCGA 
According to the standard procedure, A431 cells were transfected with two different pSpCas9 
(BB)-2A-GFP plasmids which carry the sgRNA targeting CLIP4. I then analyzed the 
transfected cells using flow cytometry by Lothar Gröbe (HZI, Braunschweig). The results of 
the FACS analysis have been depicted in Figure 40. 
Figure 39: Sequencing results confirm cloning of sgRNAs into pSpCas9(BB)-2A-GFP.The color code is as follows: 
annealed sgRNAs targeting the gene of interest (black), U6 promoter (green), overhangs (blue), additional G or C (red), and 
sgRNA scaffold (orange). 
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During flow cytometry, we detected a small population of about 6% of GFP-positive A431 
cells transfected with pSpCas9 (BB)-2A-GFP containing sgRNAs targeting the second exon 
of CLIP4. As shown in Figure 40, around 1.8% of living A431 cells were positive for 
pSpCas9 (BB)-2A-GFP containing sgRNAs targeting the fourth exon of CLIP4. In this 
experimental setup, A431 WT cells served as negative control for GFP expression. From this, 
we isolated more than 96 clones of a potential CLIP4 knockout cells in the locus. Next, the 
cells were expanded and cryopreserved as described in chapter 3.2.3. 
In parallel to the generation of knockout cell lines, we continued to monitor CLIP4 protein 
expression. However, we were unable to detect significant protein amount of endogenous 
CLIP4 (76 kDa) in WT A431 cells after long-time tissue culturing and subcloning. Since the 
expression of CLIP4 was no longer detectable in WT A431 cells, I could not confirm protein 
rundown in potential CLIP4 knockout cell lines using Western blot analysis (data not shown). 
Therefore, at this point, I couldnot carry out experiments with possible CLIP4 knockout A431 
cell lines. In the future I would plan to target CLIP4 in C2C12 cells and differentiate these 
into myotubes expressing CLIP4. The upregulation of CLIP4 in C2C12 cells upon myotube 
differentiation was repeated before us by colleagues (personal communication with Prof. Dr. 
Holly Goodson and PhD Thesis of Jill S. Voreis). 
Figure 40:Flow cytometric analysis of human epithelial tumor A431 cells transfected with pSpCas9 (BB)-2A-GFP 
which contains sgRNAs targeting for CLIP4. CLIP4 KO Exon2 and CLIP4 KO Exon4 cells were transfected with the 
respective pSpCas9 (BB)-2A-GFP-tagged constructs. All Events = total cell population, P1 = living cells, P2 = single living 
cells, P3 = single living cells, GFP- and mCherry-negative, P4 = single living cells, GFP- positive. 
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4.7.11 Generation of monoclonal antibodies to SifA and SifB 
It has been well known that SifA plays a key role in SIFs formation, but a particular function 
of SifB during Salmonella infection has still remained poorly understood. To further study 
physiological properties of SifB, I aimed at generating specific antibodies against SifA and 
SifB in collaboration with Sabine Buchmeier from the Antibody Facility of the Technical 
University Braunschweig. For this purpose, SifA ∆ext and SifB ∆ext proteins were 
overexpressed in E. coli BL21 (DE3) using the pET-41vector and purified as 6xHis-tagged 
fusion proteins as described in chapter 3.3.4. The immunization procedure lasted around 7-10 
weeks and was performed as follows. Briefly, BALB/c mice were immunized with 50 mg of 
the purified SifA and SifB proteins, and the following steps of antibody generation were 
carried out according to the standard procedure. The first ELISA screening results indicated 
96 positive clones for SifA and 65 positive clones for SifB. Next, in order to identify the most 
promising ones, the clones were expanded and the antibody titers were determined by ELISA. 
To confirm ELISA results and to assess specificity of the antibody, we employed Western 
blot assays using different controls. Of all clones tested, only clone 7H8 and corresponding 
subclones demonstrated a satisfactory signal (Figure 41). No antibody to SifB, however, could 
beisolated. 
 
 
 
 
 
As depicted in Figure 41, the produced antibodies against SifA, such as 7H8/F2, 7H8/A10 and 
7H8/24, allowed to detect protein bands corresponding to the predicted molecular weight of 
SifA (54 kDa) in extracts of GFP-SifA transfected cells. Detection with anti-GFP (ab290 and 
101G4) antibodies served as positive control. 
Figure 41:Western blot analysis using the newly generated anti-SifA antibody. Hek293T cells were transfected with 
GFP-SifA and then lysed with 4x SDS buffer. The lysates were subjected to SDS-PAGE and analyzed by Western blotting 
using newly generated anti-SifA (7H8/F2, 7H8/A10, 4D9, 7H8/24, 6G11, 6C1 and 5H3) and anti-GFP (ab 290 and 101G4) 
antibodies. The expected molecular weight of SifA is 54 kDa. 
Results 
 
82 
 
Finally, the positive clones of SifA antibody (7H8/F2, 7H8/A10 and 7H8/24) were chosen 
based on the results obtained from ELISA and Western blot analysis of recombinant and over 
expressed proteins. 
However, our attempts to produce anti-SifB antibodies were not successful in two 
independent rounds. Nevertheless, the produced SifA (7H8/F2, 7H8/A10 and 7H8/24) 
antibodies were shown to specifically recognize the protein of interest.  
 
4.7.12 Subcellular localization of GFP-tagged SifB and the co-localization studies of 
GFP-CLIP4 and Myc-SifB 
Although SifB by sequence would be highly related to SifA, the exact functions of SifB were 
still not well defined. In order to gain insights into subcellular localization of the bacterial 
virulence factor SifB, we performed immunofluorescence analysis of Cos-7 fibroblasts 
transiently transfected with GFP-SifB. Cells were fixed 24 hours post transfection, 
permeabilized and stained with phalloidin to label F-actin and with DAPI to visualize nuclei.  
The results of this experiment indicated that the ectopically expressed GFP-SifB ∆ext widely 
distributed in the cytoplasm (Figure 42, top panel). 
Next, I extended my observation and examined a potential co-localization of CLIP4 and SifB 
in Cos-7 fibroblasts. As observed earlier, SifB alone appeared mainly cytoplasmic (Figure 42, 
top panel), whereas overexpression of both GFP-CLIP4 and Myc-SifB proteins strikingly 
resulted in a partial co-localization on microtubules (Figure 42, middle panel). These data 
suggested that the microtubule-binding protein CLIP4 in principle had the capability to recruit 
SifB to microtubules. This finding together with the results of Y2H screening and pull-down 
assays corroborated the specificity of CLIP4-SifB interaction. 
In Figure 42 (bottom panel), cells expressing GFP-CLIP4 were also labeled with an antibody 
against Myc-tag and stained with DAPI. We observed that, in some cases, anti-Myc antibodies 
weakly stained microtubule-like pattern in untransfected Cos-7 cells. However, there was a 
significant difference between the background staining of Myc antibodies in the cells 
expressing only GFP-CLIP4 or co-expressing GFP-CLIP4 and Myc-SifB. 
Taken together, the data presented in Figure 42 reveal that the bacterial virulence factor SifB 
alone was distributed in the cytoplasm, but was recruited to MTs in the presence of GFP-
CLIP4. It should be emphasized that association of SifB with CLIP4 occurred most 
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prominently on microtubules. These data strongly supported the idea that host microtubule-
binding protein CLIP4 interacted with and recruited the bacterial virulence factor SifB onto 
microtubules. Besides, it was clearly shown that SifB, although binds in the CAP-Gly region 
of CLIP4, does not interfere with microtubule-binding of CLIP4. 
 
Figure 42: Subcellular localization of GFP-tagged SifB and co-localization studies of CLIP4 & SifB in Cos-7 
fibroblasts. Cos-7 cells were transfected with respective constructs, fixed 24 hours later with PFA and permeabilized 
(chapter 3.4.2). Nuclei were stained with DAPI. The actin cytoskeleton was stained with red phalloidin. Myc-tagged SifB 
protein was labeled with mouse anti-Myc antibody. Merge shows an overlay of green (the respective GFP-construct), red 
(phalloidin or anti-Myc) and blue (Dapi) channels. The scale bar indicates 10 μm. 
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4.7.13 Formation of Salmonella-induced filaments (SIFs) during infection with WT 
Salmonella in host cells 
Many research groups contributed to the investigation of Salmonella-Induced Filaments 
(SIFs) from different aspects. During the last decade, growing interest within this area helped 
to deepen our understanding of Salmonella infection. 
In order to analyze a possible function of CLIP4 during Salmonella infection, I first studied 
SIFs formation using time-lapse microscopy. Previous studies demonstrated that SIFs were 
rich in late endocytic markers, such as lysosome-associated membrane proteins (LAMPs). 
This fact made it possible to monitor the dynamic process of formation of a Salmonella-
induced tubular network in a time-lapse experiment using cells stably expressing GFP-tagged 
LAMP1.  
HeLa cells stably expressing GFP-LAMP1 (a courtesy of Prof. Dr. Mischael Hensel, 
University of Osnabrück) were seeded onto Ø 35 mm glass bottom µ-dishes (Ibidi) coated 
with fibronectin (chapter 3.4.2.5). Next, we infected these cells with wild type Salmonella 
enterica serovar Typhimurium SL1344 as described in chapter 3.5. 
As expected, after 2 h.p.i. intracellular bacteria (visible in phase contrast, not shown) were 
detected in the SCV (yellow arrows Figure 43 left top panel). Approximately 2.5 h.p.i., 
elongated filaments started to form from SCV in infected cells (red arrows, Figure 43). Later, 
long highly dynamic membrane tubules and a tubular network developed over time. The data 
of time-lapse microscopy represented in Figure 43 perfectly demonstrate almost the entire 
process of infection starting with the formation of the specialized vacuole (SCV) during the 
early stage of infection and the appearance of LAMP1-containing membrane tubules 
emanating from the SCV at later time points p.i. In agreement with previously published 
results, we confirmed that SIFs are extensive, highly dynamic membrane tubules, which start 
appearing upon infection with Salmonella (Garcia-del Portillo et al., 1993).  
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Figure 43: Time-lapse imaging of the formation of Salmonella-induced filaments (SIFs). HeLa cells stably expressing 
GFP-LAMP1 were seeded on a 3.5 cm glass bottom dish (Ibidi) coated with fibronectin and then infected with wild type 
Salmonella. After 20 min of infection cells were washed several times and incubated for 1 h in medium containing 100 μg/ml 
gentamicin. The concentration of gentamicin was then decreased to 10 μg/ml for the rest of the infection. Dynamics of the 
formation Salmonella-induced filaments (SIFs) in host cells was visualized using a Nikon BioStation IM (40X magnification) 
over 12 hours in 5 min intervals as described in chapter 3.4.2.5. Yellow arrows highlight SCVs (Salmonella not shown), 
demonstrating apparent enrichment in GFP-LAMP1. SIFs emanating from the SCV are marked with red arrows. The scale 
bar indicates 10 μm. The images were extracted from the supplementary movie 2. The time is shown in the upper right corner 
of each image and indicates hours starting from the time point of infection. 
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4.7.14 Infection assay with WT Salmonella in host cells 
To gain more insight into the possible function of CLIP4 during Salmonella infection, I 
performed time-lapse microscopy. I aimed at designing an experiment that could uncover the 
role of host CLIP4 interacting with the bacterial factor SifB. For this purpose, HeLa cells 
stably expressing GFP-LAMP1 were transfected with mCherry-labeled CLIP4 and then re-
plated onto glass-bottom dishes coated with fibronectin. Next, we infected these cells with 
wild type, SifA- and SifB-defective Salmonella as described in chapter 3.5. Comparison of 
the processes of infection with a wild type and a mutant Salmonella enterica serovar 
Typhimurium were expected to be appropriate to uncoverthe molecular role of this 
interaction. However, it was rather difficult to perform this experiment because the mCherry 
signal of CLIP4 was weak and very sensitive to bleaching. 
As shown in Figure 44, two processes could be simultaneously monitored over time in HeLa 
cells stably expressing GFP-LAMP1: 1) the formation of SCV and SIFs upon infection with 
WT Salmonella enterica serovar Typhimurium SL1344 (left panel), and 2) the dynamics of 
host microtubules decorated with mCherry CLIP4 protein (middle panel). In the upper panel 
at 2 h.p.i. the formation of SCV (left top panel, yellow arrows) is shown. In accordance with 
previous studies, approximately after 5 h.p.i. LAMP1-positive filamentous structures extend 
from this special vacuole. It was worth noting that SIFs align along MTs which were 
decorated with CLIP4. In order to perform detailed visualization of co-localization of CLIP4 
and SIFs, high-resolution microscopy should be employed. In the future we would use a super 
resolution video microscope, namely 3D-SIM, in order to visualize this situation. 
The results of time-lapse imaging of two simultaneous processes indicated that SIFs, which 
embody highly dynamic membrane tubules, aligned along CLIP4-labelled MTs during 
infection with WT Salmonella. 
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Figure 44: Time-lapse imaging of mCherry-CLIP4 during infection with WT Salmonella in GFP-LAMP1-
expressing cells. 
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HeLa cells stably expressing GFP-LAMP1 were transfected with mCherry-tagged CLIP4 construct and seeded on a 3.5 cm 
glass bottom dish (Ibidi) coated with fibronectin. Cells were infected with wild type Salmonella, washed after 20 min and 
incubated for 1 h in the medium containing 100 μg/ml gentamicin. The concentration of gentamicin was then decreased to10 
μg/ml for the rest of the infection. mCherry and GFP -signals were visualized using Nikon BioStation IM (40X 
magnification) over 12 hours in 10 min intervals. Merge shows an overlay of green (GFP-LAMP1) and red (mCherry-CLIP4) 
channels. Yellow arrows highlight SCVs (Salmonella not shown), clearly enriched in GFP-LAMP1. SIFs emanating from the 
SCV are marked with red arrows. The scale bar indicates 10 μm. The images were extracted from the supplementary movie 
3. Time points are indicated as h:min in the upper left corner of each image starting from the time point of infection. 
 
4.7.15 Infection assay with SifA defective Salmonella in host cells 
SifA is fundamental for the formation of tubular membrane extensions from SCV in HeLa 
cells, and its deficiency would result in complete loss of SIFs (Mills, 1998; Stein, 1996). In 
HeLa cells infected with a Salmonella strain lacking SifA, but harboring SifB, the latter could 
not induce SIFs. In this study, we were therefore interested whether the presence of CLIP4 
might enable Salmonella to form SIFs via SifB in the absence of SifA. Pursuing the aim to 
study this possibility, HeLa cells stably expressing GFP-LAMP1 were transfected with 
mCherry-labeled CLIP4 and then infected with a mutant Salmonella strain deficient in SifA 
(as described in chapter 3.5.). 
The data presented in Figure 45 nicely demonstrate that CLIP4-positive transfected cells were 
infected with Salmonella SifA mutant strain. In addition, after 2 h.p.i. mature SCVs were 
formed as shown in Figure 45 (top panel), with yellow arrows pointing to intracellular niches 
of bacteria. Even after 5 h.p.i. we did not observe the appearance of SIFs network (Figure 45, 
middle panel). Even after 7 hours,overexpression of CLIP4 inHeLa cells stably expressing 
GFP-LAMP1 and infected with SifA-defective Salmonella did not induce formation of 
tubular networks (Figure 45, bottom panel), in contrast to the cells infected with WT 
Salmonella (Figure 43).  
Furthermore, microscopic time-lapse studies of the behavior of individual cells during 
Salmonella infection with a SifA-defective strain demonstrated no formation of SIFs in the 
presence of CLIP4 over the 12 hours observation period (not shown). This led to the 
conclusion that CLIP4 dids not enable formation of extensive tubular membrane network 
upon infection with SifA-deficient Salmonella in HeLa cells. However, as shown by Freeman 
et al., SifB was expressed very late, after approximately 20 hours post infection (Freeman et 
al., 2003).Therefore, it was concluded that SifA, but not SifB, is essential for SIF formation. 
However, no binding partner for SifB has been known (Freeman et al., 2003) and neither of 
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currently available cell lines expressed CLIP4. Current experiments would aim at studying the 
behavior of ∆SifA Salmonella in CLIP4-expressing cells upon prolonged infection beyond 20 
h.p.i. 
 
Figure 45: Time-lapse imaging of mCherry-CLIP4 during infection with SifA defective Salmonella in GFP-LAMP1-
expressing cells. HeLa cells stably expressing GFP-LAMP1 and transiently transfected with mCherry-tagged CLIP4 
construct were seeded on a 3.5 cm glass bottom dish (Ibidi) coated with fibronectin. Cells were infected with SifA-defective 
Salmonella. After 20 min post infection, the cells were washed several times and incubated for 1 h in the medium containing 
100 μg/ml gentamicin. The concentration of gentamicin was then decreased to 10 μg/ml for the rest of the infection. mCherry 
and GFP-signals were visualized using a Nikon BioStation IM (40X magnification) over 12 hours in 10 min intervals. Merge 
shows an overlay of green (GFP-LAMP1) and red (mCherry-CLIP4) channels. Yellow arrows highlight SCVs (Salmonella 
not shown), demonstrating apparent enrichment in GFP-LAMP1. SIFs emanating from the SCV are marked with red arrows. 
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4.7.16 Infection assay with SifB defective Salmonella in host cells 
In contrast to the critical role of SifA in the formation of SIFs, SifB was not known to be 
involved in this process. In the next experiments, I tested whether intracellular phenotypic 
differences occur when the cells were infected with a SifB mutant strain. Corresponding 
images have been shown in Figure 46. 
I observed a typical formation of the SCV membrane and long tubules enriched in LAMP1, 
which extended from the SCV also with SifB-defective Salmonella (Figure 46, left panel). In 
accordance with the previously published data (Freeman et al., 2003), deletion of the bacterial 
virulence factor SifB appeared to have no dramatic effect on the cell’s behavior during 
Salmonella infection and in the presence of CLIP4 (Figure 46). 
 
Figure 46: Time-lapse imaging of mCherry-CLIP4 during infection with SifB defective Salmonella in GFP-LAMP1-
expressing cells. HeLa cells stably expressing GFP-LAMP1 and transfected with mCherry-tagged CLIP4 were seeded on a 
3.5 cm glass bottom dish (Ibidi) coated with fibronectin. Cells were infected with SifB-defective Salmonella, washed after 20 
min post infection and incubated for 1 h in the medium containing100 μg/ml gentamicin. The concentration of gentamicin 
was then decreased to10 μg/ml for the rest of the infection. mCherry-CLIP4 and GFP-LAMP1 were visualized with Nikon 
BioStation IM (40X magnification) over 8 hours in 10 min intervals. Merge shows an overlay of green (GFP-LAMP1) and 
red (mCherry-CLIP4) channels. Yellow arrows highlight SCVs (Salmonella not shown), clearly enriched in GFP-LAMP1. 
SIFs emanating from the SCV are marked with red arrows. The scale bar indicates 10 μm. The time is indicated in h: min, 
starting from the time point of infection. 
Taken together, the above data allowed me to conclude that there was no significant 
difference in SIF formation regardless of presence or absence of CLIP4 or SifB. The presence 
or absence of neither SifB nor CLIP4 affected the known dynamics of SIF-formation in HeLa 
cells. However, the long-term fate of Salmonella and very late stages of SIF formation would 
still need to be analyzed.  
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5. DISCUSSION 
This study aims at determining novel binding partners of bacterial virulence factors that 
belong to the WxxxE family. First, the Y2H screening is performed to identify new host-
pathogen interactions where WxxxE effector proteins were used as baits and a human cDNA-
based protein library as prey. The identified Y2H hits are evaluated and pre-selected based on 
known or expected biological functions and localization of these proteins.Next, we define a 
set of putative interaction pairs, among them APPL1/EspT, Cep70/SifA, DYNLRB1/SifA, 
and CLIP4/SifB, and analyse them using biochemical and microscopic techniques. 
Unfortunately, the interaction between APPL1 and EspT cannot be readily confirmed under 
the chosen experimental conditions. Therefore, I did not continue this subproject in the 
framework of this thesis. Notwithstanding this, EspT is included as a control for biochemical 
experiments with SifA and SifB because it belongs to the same protein family but is expected 
to have entirely different functions.  
 
5.1 SifA and its host interaction partners 
Salmonella that successfully reached the intracellular space secretes an array of bacterial 
virulence factors, among themSifA, into the host cytoplasm via the T3SS II (Miao et al., 
2000). A significant feature of SifA as a key virulence factor in the pathogenesis of 
Salmonella is the maintenance of the SCV and the involvement in the formation of SIFs 
(LAMP-1-enriched membrane tubules) which originate from SCV, spreading out along 
microtubules. Furthermore, the Salmonella effector protein SifA belongs to the WxxxE family 
that is composed of 24 members that share the conserved WxxxE motif (Alto at al., 2006). 
Some members of this family function as bacterial GEFs to activate Rho GTPases, but so far 
it is not yet  demonstrated whether SifA has a GEF activity similar to the EPEC/EHEC 
effector Map and Shigella effectors IpgB1 and IpgB2 (Huang et al., 2009; Klink et al., 2010). 
Nevertheless, Ohlson and colleagues have earlier reported that SifA binds to the GDP-bound 
inactive form of the GTPase RhoA (Ohlson et al., 2008). Furthermore, recent studies reveal 
that SifA interacts with several host proteins during Salmonella infection as described below. 
 
One molecular target of SifA is the host protein SKIP (SifA and kinesin-interacting protein) 
that downregulates kinesin motor activity on the SCV and regulates bacterial vacuole 
dynamics (Boucrot et al., 2005). This interaction is mediated via the pleckstrin homology 
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(PH) domain of SKIP (Diacovich et al., 2009). On the other hand, SKIP interacts specifically 
and directly with the late endosomal marker Rab9 through the same PH domain, but in the 
presence of SifA this interaction is affected (Jackson et al., 2008). Furthermore, in the work of 
Jackson and colleagues it is postulated that WxxxE motif of SifA is essential for the 
interaction with host proteins. Finally, McEwan and colleagues have recently demonstrated 
that the host Pleckstrin homology domain-containing protein family member 1 (PLEKHM1), 
which shares a similar domain structure with SKIP, interacts with the N-terminal domain of 
SifA through its second PH domain (PH2) (McEwan et al., 2015). In their work, a specific 
interaction between the PH2 and C1/ZnF domains of PLEKHM1 and a small GTPase Rab7, 
but not Rab9, can be shown. 
 
Among several putative interaction partners of SifA identified in the Y2H screen, I select two 
proteins, Cep70 and DYNLRB1, for our study. Furthermore and following independent lines 
of evidence, I include analyses on the interaction of SifA with the GTPases Rab6 and Rab9.  
 
5.1.1 Cep70 as a potential target of SifA 
The first interaction pair to be validated is Cep70 and SifA. Cep70 is a protein of 70 kDa, 
which belongs to the centrosomal protein (Cep) family comprising 31 members (Andersen et 
al., 2003; Kumar et al., 2013). Cep proteins are components of centrosome that functions as a 
microtubule-organizing center (MTOC). The centrosome is involved in various fundamental 
processes, including mitosis, cell migration and polarization (Doxsey et al., 2005). Shi and 
colleagues have observed that the centrosomal localization of Cep70 is dependent on its N-
terminal coiled-coil domains that also mediate the interaction with γ-tubulin (Shi et al., 2011). 
Using microtubule depolymerization assays, the authors demonstrate that this N-terminal 
region of Cep70 regulates microtubule stability by increasing tubulin acetylation (Shi et al., 
2015). It is worth to notice that knockdown of Cep70 expression significantly reduces the 
level of tubulin acetylation (Shi et al., 2015). The interaction between Cep70 and the 
microtubule-associated deacetylase HDAC6 is also mediated by the coiled-coil domains of 
Cep70 (Hubbert et al., 2002; Shi et al., 2015). Thus, the authors come to the conclusion that 
Cep70 promotes microtubule stabilization via directly binding to and inhibiting HDAC6 (Shi 
et al., 2015). The biological functions of Cep70 as listed above allow us to assume the 
existence of an interaction between the centrosomal protein Cep70 and the WxxxE effector 
protein SifA, which is important for positioning of the SCV in the centrosomal region and for 
spreading SIFs along stable microtubules. 
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In my experimental setup, I show by immunofluorescence microscopy thatectopically 
expressed Cep70 in most cases exclusively accumulates at the two centrioles (Figure 13, top 
panel). However, in some cases, Cep70 displays a distinct phenotype, which is reflected by so 
called centriolar satellites (CS) that cluster in the vicinity of the centrosome. This phenotype 
is similar to that observed for other CS proteins such as Cep72, Cep90 and Cep131 
(Tollenaere et al., 2015). Akin to Cep70, the pericentriolar material 1 protein (PCM1) – one of 
the first CS proteins discovered – contains a coiled-coil motif at the N-terminal region that is 
essential for protein-protein interactions (Tollenaere et al., 2015). Furthermore, CS proteins 
are involved in centrosome biogenesis, ciliogenesis, and neurogenesis.At the same time, our 
co-localization studies of Cep70 and the Salmonella bacterial virulence factor SifA reveal that 
SifA distributes throughout the cell but with clear accumulation in the vicinity of Cep70, 
which localizes in small granules (Figure 13, bottom panel). These data suggest that Cep70 
and SifA can in principle co-localize in the same cell compartment.  
However, I have not been able to successfully perform biochemical studies due to technical 
problems intrinsic to Cep70: Cep70 concentrated mainly in the triton-insoluble fraction when 
preparing cell lysates. Thus, protein/protein interaction studies are hampered by the virtual 
absence of Cep70 in the soluble fraction. Nevertheless, Cep70 protein remains an interesting 
candidate for our research as it is associated with centrosomes, a position of mature SCV in 
the later stage of infection with Salmonella, and/or potential component of centriolar 
satellites. Thus, the interaction between centrosomal protein Cep70 and SifA may well exist 
and be relevant, yet a comprehensive analysis is needed in order to verify this possibility. 
 
5.1.2 DYNLRB1 might be a potential SifA target 
According to the data from the previously conducted Y2H screen, DYNLRB1, a member of 
the roadblock dynein light chain family, has been identified as a potential interacting partner 
of SifA. Cytoplasmic dynein consists of two heavy chains (DYNC1H1 and DYNC2H1), 
which are required for microtubule binding and ATPase activity; two intermediate chains 
(DYNC1I1 and DYNC1I2); two light intermediate chains (DYNC1LI1 and DYNC1LI2); and 
several light chains, including DYNLRB1 and DYNLRB2 proteins (Pfister et al., 2006; 
Wanschers et al., 2008). Dyneins embody one of the two families of molecular motors, 
namely kinesins and dyneins, accomplishing the transport of intracellular cargos in eukaryotic 
cells along microtubule tracks (Figure 47). In fact, intracellular Salmonella at early time 
points post infection exploits the minus-end-directed motor dynein, to reach the final SCV 
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position in the perinuclear area. Localization of the SCV is highly coordinated by T3SS-2 
effector proteins including SifA (Henry et al., 2006), why we consider DYNLRB1 and SifA 
as a potential biologically relevant pair of interaction partners.  
 
 
 
 
 
 
 
 
 
Cytoplasmic dynein is essential for minus end-directed transport towards the perinuclear region whereas kinesin moves 
various cargoes towards the plus ends in the cell periphery. Cytoplasmic dynein consists of heavy chains (red) that are 
required for microtubule binding and ATPase activity; intermediate chains (yellow); light intermediate chains (indigo) and 
several light chains (light pink, green, orange). Dynactin interacts with dynein and harbors several subunits, among them 
p150Glued (turquoise), that binds to the dynein intermediate chain (yellow) and to microtubules via a CAP-Gly motif at the tip 
of its globular heads. Association of Dynactin with cargo is mediated by the dynactin subunit p50 (dark pink).  
Kinesin comprises two heavy chains, known as microtubule binding and motor subunits (red), and two light chains (green). 
Cargo-binding is mediated by an intermediate scaffold protein (blue) that can bind to transmembrane cargos (yellow) 
(Duncan & Goldstein, 2006). 
The cytoplasmic localization of DYNLRB1 in transiently transfected Cos-7 cells (Figure 15, 
top panel) is in line with earlier observations made by the group of Jack Fransen (Wanschers 
et al., 2008). Detailed co-localization analysis of DYNLRB1 and Rab6 reveal that 
cytoplasmic DYNLRB1 is recruited to the Golgi region in a Rab6-dependent manner 
(Wanschers et al., 2008). My results are fully consistent with these published data 
demonstrating that DYNLRB1 interacts and co-localizes with Rab6 in the Golgi region 
(Figure 16, upper middle panel). Furthermore, the small GTPase Rab6 is known to be 
essential for the retrograde transport pathway from endosomes through the Golgi to the 
endoplasmic reticulum (White et al., 1999). In addition, Rab6 interacts with the p150
Glued 
subunit of the dynactin complex and recruits dynactin to the Golgi membrane. Likewise, Rab6 
specifically interacts with the cargo adaptor protein Bicaudal D2 (BICD2) that couples to the 
p50 subunit of the dynactin complex (Short et al., 2002). Noteworthy, cytoplasmic dynein 
Figure 47: Molecular motors along microtubular tracks. 
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interacts with dynactin to drive cargo along microtubules. The stable dynein-dynactin-
BICD2N (DDB) complex is formed only when all three proteins are present (Splinter et al., 
2012; McKenney et al., 2014; Urnavicius et al., 2015; Matanis et al., 2002). In addition, the 
DDB complex binds to microtubules as exemplified by using negative stain electron 
microscopy and 2D analysis (Chowdhury et al., 2015). 
Noteworthy, co-localization of the small GTPase Rab6 with SifA is very apparent at the Golgi 
complex (Figure 16, lower middle panel). This finding allows me to conclude that Rab6 alone 
already has a significant ability to recruit SifA from the cytoplasm to the Golgi region. 
Furthermore, simultaneous overexpression of three proteins – DYNLRB1, SifA and Rab6 – 
resulted in their pronounced accumulation at the Golgi complex, close to the replication 
position of Salmonella (Figure 16, bottom panel).I hypothesize that Rab6 might be required 
for the interaction of SifA with DYNLRB1. This might in turn be important for intracellular 
replication of Salmonella which takes place in the SCV in close vicinity of the Golgi 
apparatus. As previously mentioned, this special localization of the SCV in the perinuclear 
region is tightly regulated by T3SS-2 effector proteins, including SseG, SseF and SifA. 
Despite the interaction between DYNLRB1 and SifA in our Y2H screen, I cannot readily 
observe binding of the two proteins in our pull-down assays. Notwithstanding this, I have 
found a weak interaction under buffer conditions where no detergent was present or the water 
activity was reduced (high salt), which is conclusive with a near-membrane-interaction in the 
cell (Figure 17). Since the small GTPase Rab6 has the ability to recruit SifA and DYNRB1 to 
the Golgi, we tested whether the presence of Rab6 would bind to SifA or promote a putative 
interaction between SifA and DYNLRB1. However, neither Rab6 binding nor increased 
DYNLRB1 binding is observed under our experimental conditions (Figure 18). It may be 
worth to revisit this question using different ‘membrane-friendly’ conditions such as cell 
fractionation.  
Intracellular pathogenic Salmonella exploits host cell trafficking pathways, which are 
regulated by a complex network of Rab GTPases, in order to promote SCV maturation 
(Brumell & Scidmore, 2007). Furthermore, Rabs concentrate at distinct subcellular 
compartments in mammalian cells (Figure 48) (Zerial & McBride, 2001; Jean & Kiger, 2012; 
Hutagalung and & Novick, 2011).  
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Among 18 Rabs proteins that have been found to be present at the SCV during maturation, 
only two, namely Rab7 and Rab9, are required for the formation of SIFs (Brumell & 
Scidmore, 2007). Thus I probed the ability of these Rab GTPases to bind to SifA or to impact 
on SifA/DYNLRB1 binding. Using pull-down assays, we identify the ability of the WxxxE 
domain of SifA to bind specifically to the late endosomal marker Rab9 (Figure 19 and 
preliminary work in the PhD Thesis of S. Arens). This finding certainly has biological 
relevance since SifA and Rab9 are both involved in the formation of SIFs and plus Rab9 
shares a binding partner, namely SKIP, with SifA. Since no target GTPase for SifA can be 
identified among the Rho-family of small GTPases, it is tempting to speculate that SifA 
embodies a bacterial GEF for Rab9. SifA shares the GEF-like fold with the Rac/Cdc42 GEF 
SopE.(Alto et al., 2006; Ohlson et al., 2008) but not with other known bacterial Rab-GEFs. 
Moreover, despite SifA binds to a GDP-bound RhoA (Ohlson et al., 2008), recent structure 
models of the IpgB2-RhoA complex and its overlay with SifA structure reveal that interaction 
between SifA and RhoA is highly unfavorable since SifA harbors a more extended catalytic 
loop when compared to IpgB2 (Klink et al., 2010).Since Rab-GTPases are distantly related to 
Rho GTPases (both belong to the Ras-superfamily), a potential evolution of Rab-GEF activity 
within this branch of bacterial GEFs is thinkable and attractive.  
In my thesis work, I can readily confirm a significant interaction between SifA and Rab9 (but 
not Rab6) in pull-down assays (Figure 19). Hence, I here suggest that SifA may function as 
bacterial GEF for Rabs (i.e.Rab9) rather than Rho-GTPases. This will also be compatible with 
either exclusive or competitive binding of Rab9 to its GEF (SifA) or effector (SKIP) as 
Figure 48: Intracellular localization of Rab 
GTPases in eukaryotic cells. Rab1 regulates ER-
Golgi traffic. Rab4, Rab5 and Rab21 associate to early 
endosomes. Rab6 is involved in retrograde Golgi-ER 
and intra Golgi- transport pathways. Rab7 and Rab9 
both localize to late endosomes, and Rab9 also 
regulates membrane traffic between late endosomes 
and the trans-Golgi network (Hutagalung and & 
Novick, 2011). Rab11, Rab25 and Rab35 localize to 
recycling endosomes. Rab33 associates with the Golgi 
apparatus (Jean & Kiger, 2012). 
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described (Ohlson et al., 2008). It will be exciting to experimentally challenge this hypothesis 
e.g. by solving the crystal structure of WxxxE domain of SifA from Salmonella in complex 
with Rab9 and/or by conducting in vitro GTP-exchange assays. However, this aim lies beyond 
the scope of the present thesis and must be addressed in further studies. 
Nonetheless, I analyze whether interaction between SifA and Rab9 has an influence on the 
binding of SifA to DYNLRB1. However, the interaction between DYNLRB1 and SifA 
remain at or below detection levels as before, despite the presence of the small GTPase Rab9 
and its clear binding to SifA (Figure 20). Also here a fine tuning of experimental conditions 
may help to dissect DYNLRB1, Rab6 or Rab9 binding to SifA.  
Remarkably, Rab9 subcellularly localizes in a manner similar to the Rab6 (Figure 21, top 
panel). Our data demonstrate that the expression of Rab9 has a dramatic effect on the 
subcellular distribution of SifA, leading to a virtually complete recruitment of cytoplasmic 
SifA to the Golgi region by Rab9 (Figure 21, lower middle panel). Finally, co-overexpression 
of Rab9 and SifA leads to partial re-localization of cytoplasmic DYNLRB1 to the Golgi 
region (Figure 21, bottom panel). Interestingly, in contrast to Rab6, Rab9 cannot translocate 
DYNLRB1 to the Golgi in the absence of SifA, suggesting a different behavior of Rab9 
compared to Rab6. Figure 49 illustrates different cascades of recruitment of DYNLRB1 and 
SifA to the Golgi by Rab6 and Rab9 GTPases.  
 
Figure 49: Schematic illustration of the potential signaling/recruitment cascades of Rab6 and Rab9 leading to 
translocation of SifA DYNLRB1. Aster marks a potential GEF activity of SifA towards Rab9. 
However, in this study neither Rab6 nor Rab9 can promote the interaction between SifA and 
DYNLRB1. Hence, in addition to the above experiments, comprehensive studies must be 
conducted to determine whether the interaction between cytoplasmic dynein, DYNLRB1, and 
WxxxE effector protein SifA depends on the presence of additional cofactors. Currently, I 
cannot exclude the possibility that SifA binds indirectly to the microtubule motor protein, 
DYNLRB1. Considering the fact that Rab6 has a unique ability to recruit a large dynein-
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dynactin-BICD2N complex, which transports various cellular cargo towards the minus ends 
of microtubules and Salmonella to their specific subcellular location, it is reasonable to probe 
the members of this complex for such a role. Strikingly, bicaudal has also been identified in 
the Y2H list of potential interactors but as yet no further analysis is done. This explains the 
fact that progress of the SifB/Clip4 interaction outperforms this subproject (see 5.2). 
 
5.2 The interaction between CLIP4 and SifB 
Based on the results of Y2H screening, CLIP4 has been identified to be a potential target of 
the Salmonella effector protein SifB. The Salmonella virulence factor SifB, similarly to SifA, 
belongs to a large family of 24 proteins that harbor a common WxxxE motif at the C-terminal 
region (Alto et al., 2006). Within this protein, SifA and SifB form a subgroup because they 
both harbor a conserved N-terminal extension, which in the case of SifA connects to SKIP 
and kinesin (see above). Since this work and the prior Y2H screen is set out to identify 
interactors of WxxxE proteins, I have designed and used throughout SifA- and SifB variants 
lacking the N-terminal extension (termed Δext) if not stated otherwise. It is known that SifB 
is translocated by the SPI2-encoded T3SS into the host cell at late to very late stages (after 20 
hours post infection) (Freeman et al., 2003), but the exact role of SifB in the course of 
Salmonella infection is not understood. In fact, a mutant lacking SifB did not show any 
phenotype in vitro infection assays using HeLa cells (Rajashekar et al., 2014).  
CLIP4, in turn, belongs to the CAP-GLY Domain Containing Linker Proteins family. The 
members of this family are defined based on the presence of an ~80 amino acids protein 
module, which is highly conserved among organisms ranging from yeast to human 
(Riehemann & Sorg, 1993; Weisbrich et al., 2007). This module, called cytoskeleton-
associated protein-glycine-rich (CAP-Gly) domain, has been first discovered in 1993 
(Riehemann & Sorg, 1993) and found in functionally diverse proteins, such as cytoplasmic 
linker proteins (CLIPs and CLIPRs), large subunit of the dynactin complex p150Glued, 
tubulin-folding cofactors B and E, centrosome-associated protein-350 (CAP350), the kinesin 
protein KIF13B or the familial cylindromatosis tumor suppressor CYLD (Weisbrich et al., 
2007; Steinmetz & Akhmanova, 2008).  
CLIP1 and CLIP2 (also known as CLIP170 and CLIP115, respectively) are the best 
characterized representatives of the CAP-Gly family and are known as microtubule plus-end 
tracking proteins (+TIPs) (Pierre et al., 1992; Akhmanova & Steinmetz., 2010; Akhmanova & 
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Steinmetz., 2008; Galjart, 2005). In contrast to CLIP2, CLIP1 contains zink-binding domains 
(ZnF) and an EEY/F motif necessary for interaction with the CAP-Gly domain of p150Glued, 
and the dynein regulator LISI (Lansbergen et al., 2004; Coquelle et al., 2002). Two major 
+TIPs, CLIP170 and p150Glued, bind to the C-terminal EEY/F motifs of end-binding (EB) 
proteins through their CAP-Gly domains. Interestingly, CLIP3 (CLIPR-59), which is closely 
related in its sequence to CLIP4 (Steinmetz & Akhmanova, 2008), exclusively localizes to the 
Golgi and trans-Golgi region. This is shown to solely depend on a palmitoylated membrane-
targeting motif (PMT) enclosed within the last 30 amino acid residues (Figure 30, top panel). 
CLIP3 is believed to be involved in the early/recycling endosome–TGN transport pathway 
(Perez et al., 2002; Lallemand-Breitenbach et al., 2004 ) and has been shown to interact with 
the kinase domain of Akt by means of its first CAP-Gly domain, regulating its membrane 
localization (Ding et al., 2009). Finally, CLIP3 expressed in the neuronal system and a 
knockout show defects in neuromuscular junction formation leading to late embryonic or 
neonatal lethality (Couesnon et al., 2013)  
CLIP4 contains three ankyrin-repeats in its N-terminus, followed by three CAP-Gly domains, 
with a basic serine region in between 1
st
 and 2
nd
 CAP-Gly domains (Figure 22). Regarding the 
biological function, subcellular localization or protein expression of CLIP4, there are no 
studies available. In contrast to the well-studied CLIP1 and CLIP2, the fourth member of the 
CAP-Gly family, CLIP4, is a yet uncharacterized protein. Therefore, I started studying 
subcellular localization of CLIP4 in Cos-7 cells transiently transfected with its GFP-fusion 
construct. Microscopy analysis demonstrates that CLIP4 is a microtubule-binding protein 
(Figure 23, top panel) rather than a +TIP, like CLIP1 and CLIP2. I perform time-lapse 
microscopy in order to visualize dynamic behavior of individual GFP-CLIP4-transfected Cos-
7 cells (Figure 24), supporting the notion that is decorating microtubules along their length 
and is not enriched at their tips. Moreover, I observe substantial bundling of microtubules 
which is augmented with increasing ectopic expression levels.  
In order to identify the domains required for microtubule localization, I design constructs that 
harbor ankyrin-repeats and CAP-Gly-domains with a basic serine region of human protein 
CLIP4. The results unambiguously demonstrate that the CAP-Gly domains with the basic 
serine stretch are essentially required and sufficient for microtubule binding and bundling, 
whereas the localization of the isolated Ankyrin repeats remains cytoplasmic (Figure 23). 
Interestingly, similar binding characteristics have been described for the CAP-Gly-domainy of 
CYLD (Wickström et al., 2010) and the basic region within Ras association domain family 
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1A (RASSF1A) that also stabilizes and bundles MTs via this basic region (Rong et al., 2004; 
Arnette et al., 2014).  
Strikingly, these proteins belong to a class of structurally very divergent proteins that all share 
a role as tumor suppressors as they all stabilize interphase microtubules and (epithelial) cell 
polarity, thus prohibiting proliferation and migration (Hernandez & Tirnauer, 2010). Merlin 
(Muranen et al, 2007) and von-Hippl-Lindau-Syndrome-protein (Hergovich et al, 2003) also 
belong to this class of proteins. A hallmark of this feature is that i) microtubules are stabilized 
in a way that they are protected from the de-polymerizing effect of nocodazole and ii) that 
microtubules are then longer lived and thus accumulate post-translational modifications such 
as acetylation of alpha-tubulin. These effects have been observed for the above mentioned 
members of this call of tumor suppressing protein and have prompted members of the lab here 
to probe this features also for CLIP4. In fact, both parameters could be detected (see 
supplemental Figure 50; a courtesy of Theresia Stradal & Annette Otto, HZI, Braunschweig), 
suggesting that CLIP4 also functions as tumor suppressor. 
In this context I then analyze the expression pattern of CLIP4 in human and mouse tissues 
using data available from different data bases e.g. the GEO database providing GeneChip 
datasets. In fact these analyses uncover that CLIP4 is not expressed in constantly dividing 
cells (see Figure 37 and 38) and even downregulated in cells that are experimentally 
stimulated to proliferate. This is a clear indication for CLIP4 acting as tumor suppressor gene 
in selected tissues- according to its expression pattern- in skeletal muscle and/or parts of the 
digestive tract. This in turn highlights its potential involvement in Salmonella infection. 
Thus, CLIP4 interaction with SifB may play a role in very late stages of Salmonella infection, 
when bacteria has reached tissues consisting mostly of quiescent, non-cycling cells and thus 
expressing CLIP4. To corroborate this at least in vitro, I examine the distribution and 
behavior of GFP-SifB when transiently transfected into Cos-7 cells (that lack endogenous 
CLIP4) or ectopically co-expressing with CLIP4. As shown in Figure 42 (top panel), SifB 
alone is mostly dispersed throughout the cell. Furthermore, I provide evidence that CLIP4 and 
SifB co-localize significantly on microtubules (Figure 42, middle panel). 
The interaction between the host protein CLIP4 and the T3SS-2 effector protein SifB is 
further verified by pull-down assays. The specificity of this interaction can be confirmed since 
none of the other WxxxE effector proteins such as SifA and EspT, interacts with CLIP4 
(Figure 25 B). Moreover, I successfully map interaction surfaces between the two proteins, 
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SifB and CLIP4, using individual domain-based constructs of CLIP4 in pull-down assays. I 
demonstrate that the C-terminal region harboring CAP-Gly domains and basic serine stretch 
of CLIP4 is necessary and sufficient for the interaction with SifB, but not with the related 
protein SifA (Figure 26A). In contrast to CLIP4, I did not observe an interaction between SifB 
and CLIP1 or CLIP2 in our pull-down assays, although the latter two proteins belong to the 
same protein family and share similar CAP-Gly domains with CLIP4 (Figure 34). Despite the 
weak but significant ability of CLIP3 to interact with Salmonella effector protein SifB in the 
pull-down assay, this interaction is not likely of biological relevance, since the third member 
of CAP-Gly family, CLIP3, appears to be expressed in adipose and brain tissue (Ding et al., 
2009), which are normally not infected by Salmonella.  
The data suggests that CLIP4 specifically interacts with the WxxxE domain of SifB via its 
second and third CAP-Gly domains, which follow the central basic serine region (Figure 27 
D). 
In order to gain insight into interaction between virulence factors and host proteins, we aim to 
generate mouse monoclonal antibodies against SifA and SifB, in collaboration with 
colleagues from the TU Braunschweig (Sabine Buchmeier), a specific anti-SifA monoclonal 
antibody is established, which will be a valuable tool in future studies. However, despite our 
careful attempts, we did not succeed in producing anti-SifB antibodies.  
In this study, in order to analyze cellular phenotypes as well as alterations during infections 
with wild-type and SifB-defective Salmonella, I also aim at generating somatic knockouts for 
CLIP4 using the CRISPR-Cas technology. Although I find small amounts of CLIP4 to be 
endogenously expressed in the A431 cell line, I fail with this approach because all clones, no 
matter if treated with guide RNAs specific to CLIP4 or not, did not lose residual expression. 
One possible and likely explanation is that subcloning of the cells during establishment of 
targeted clones selects the cells for continuous cycling, which in turn results in shutting down 
CLIP4 expression. Therefore, I have discontinued further experiments in this direction. Here, 
I also emphasize that in the majority of immortal cell lines I did not detect any CLIP4 (Figure 
38), which is in accordance with the data obtained with Gene Chip analysis (Figure 37). In the 
future, it may be useful to target stem cell-like cells and then differentiate them into specific 
lines that are capable of CLIP4 expression.  
Next, I investigate localization of CLIP4 with respect to SIF-dynamics in Salmonella infected 
cells. First, we study the dynamic process of formation SIFs in HeLa cells stably expressing 
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GFP-tagged Lamp1 infected with wild-type Salmonella spp. using long-term time-lapse 
microscopy (Figure 43). These results are consistent with previously published data, which 
demonstrated that SIFs spread throughout the entire cell to form a complex network (Garcia-
del Portillo et al., 1993; Rajashekar et al., 2008). Furthermore, Brumell and colleagues 
demonstrate that SIFs are formed along microtubules that serve as cytoskeleton scaffold for 
them, and that depolymerization of the microtubule network disrupted SIFs (Brumell et al., 
2002; Garcia-del Portillo et al., 1993). Next, I analyze the behavior of CLIP4 in HeLa cells 
stably expressing GFP-LAMP1 and transiently transfected with mCherry-CLIP4 upon 
infection with wild-type, SifA- or SifB-defective Salmonella. Remarkably, extensive highly 
dynamic SIFs align along microtubule-binding protein CLIP4 during the course of infection 
with wild-type Salmonella (Figure 44) or SifB-deficient bacteria. However, the presence of 
CLIP4 is not sufficient to induce SIF-formation upon infection with SifA-defective 
Salmonella (Figure 45) in infection experiments up to 12 hours. Notwithstanding this, it is 
still reasonable to assume that SifB has such (or similar) function in late stages, because in an 
earlier report it was described to occur not before 20 hours post infection in vivo. Due to the 
lack of a good antibody the time point of expression of SifB in the current thesis is not 
monitored.  
Therefore, a potential role of SifB in the formation of SIFs has not been found until now 
probably because SifB did not induce SIFs when studied in immortal cell lines lacking 
endogenous CLIP4 such as HeLa.  
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5.3 Concluding remarks 
In this study, I validate several hits from a previous Y2H screen for host-specific interactors 
of members of the WxxxE family. By using biochemical and microscopic techniques, in order 
to identify new host binding proteins of bacterial virulence effectors, I here report the 
validation of two interactions. This study provides strong indications for an interaction 
between SifA and Cep70, which might well be involved in SCV positioning. Also, this work 
corroborates the intimate interplay with Rab-GTPase signaling and highlights a potential 
additional function for the WxxxE domain of SifA as GEF for Rab9. Finally it provides 
strong evidence for the interaction between the host microtubule-binding protein CLIP4 and 
the Salmonella WxxxE effector protein SifB. The interaction surface between these two 
proteins to the C-terminal region containing CAP-Gly domains and a basic serine stretch of 
CLIP4 is mapped. Moreover, both proteins have been shown to co-localize on microtubules. 
In addition, CLIP4 behaves similarly to other tumor suppressor proteins such as RASSF1A 
and VHL-Sp, which stabilize interphase-microtubules, thus prohibiting cell cycle. Therefore, 
we assume that CLIP4 may also serve as a tumor suppressor protein in certain tissues. 
However, the biologic relevance of the interaction between CLIP4 and SifB – although 
anticipatable- remains to be shown. 
Investigation of how WxxxE effector proteins manipulate host proteins will offer deeper 
insights into the multitude of biologic activities exerted by these bacterial virulence factors 
during infection. Exact molecular mechanisms of these host-pathogen interactions in the 
course of infection will lead to new strategies in fighting infectious disease. 
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6. SUMMARY 
Even in the twenty-first century, infectious diseases remain a global health problem. The 
World Health Organization (WHO) continuously registers incidents of Salmonella infections 
in both developed and developing countries. During long-standing co-evolution with their 
hosts, pathogenic bacteria have evolved multiple strategies to survive and replicate within the 
host by manipulating intracellular signaling pathways. Furthermore, an array of bacterial 
virulence factors is delivered into the host cytoplasm upon infection via the type three 
secretion system (T3SS). Alto and colleagues grouped 24 effector proteins, including Map, 
EspM and EspT of EHEC/EPEC and the related Citrobacter rodentium, IpgB1 and IpgB2 of 
Shigella sp, and SifA and SifB of Salmonella sp, that share a common motif WxxxEinto a 
single family (Alto et al., 2006). These WxxxE proteins mostly act as bacterial guanine 
nucleotide exchange factors (GEFs) towards Rho GTPases. Structural studies of WxxxE-
family GEFs showed that these effectors share a common fold with Salmonella SopE and 
SopE2 (Buchwald et al., 2002; Ohlson et al., 2008; Huang et al., 2009). The latter are known 
to mimic eukaryotic GEFs by targeting Rho GTPases. However, WxxxE effectors SifA and 
SifB appear to lack GEF-activity towards Rho-GTPases, which opens up new questions on 
investigating the molecular function of these effector proteins during infection. 
In this regard, the present study focuses on the identification of new host cell targets of a 
number of various bacterial virulence factors, including SifA, SifB and EspT. Based on the 
results of a previously conducted Y2H screening, we preselect four most prominent host-
pathogen pairs (APPL1 and EspT, Cep70 and SifA, DYNLRB1 and SifA, CLIP4 and SifB) 
for our study. 
I perform pull-down assays in order to validate the interactions predicted by the Y2H screen. 
Interaction of EspT and APPL1 can not be confirmed with this approach and thus it has been 
excluded from further analyses. 
Similarly, an interaction between a host protein Cep70 and a bacterial virulence factor SifA, 
can not be demonstrated in these experiments, because Cep70 accumulated in the triton-
insoluble fraction. Centrosomal proteins form complexes that can either be included in the 
centrosome or in so calledcentriolar satellites. Taking into account the fact that Cep70 
localizes at centrosomes, where also Salmonella-containing vacuoles (SCVs) migrate after 2 
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hours post invasion, the putative interaction between Cep70 and SifA is still considered to be 
of potential interest. However, this is not followed further in this thesis. 
Another predicted interaction partner of the WxxxE effector SifA is DYNLRB1. It is difficult 
to demonstrate the interaction under chosen experimental conditions in pull-down assays. 
However, when using immunofluorescence microscopy, a partial co-localization of 
DYNLRB1 with SifA is readily observed; at the same time, the small GTPase Rab6 can 
recruit DYNLRB1 to the Golgi in accordance with the previously published data (Wanschers 
et al., 2008). Furthermore, co-expression of DYNLRB1, Rab6 and SifA leads to compact 
localization of all three proteins at the Golgi structure. Therefore, the results of our Y2H 
screen together with co-localization studies support idea that DYNLRB1 interacts with SifA. 
Within the framework of this study, I have succesfully identified a novel interaction between 
the host protein CLIP4, the function of which has been unknown until now, and the bacterial 
virulence factor SifB. The interaction surface of these two proteins has been mapped to the C-
terminal CAP-Gly domains of CLIP4. Furthermore, SifB is shown to specifically interact with 
CLIP4, but not with other members of The CAP-Gly family (CLIP1, CLIP2, or CLIP3). 
Using microscopic techniques, it has been revealed that CLIP4 is a microtubule-binding 
protein. In particular, it demonstrates that this feature is mediated via the Cap-Gly-domains 
and not the ankyrin repeats. In addition, the work presented here shows that the bacterial 
virulence protein SifB alone is diffusely distributed throughout the cytoplasm, but is recruited 
to microtubules in the presence of CLIP4. Finally, co-localization of Salmonella-induced 
membrane tubules, termed SIFs, with CLIP4-labelled microtubules can be visualized using 
time-lapse microscopy. In the view of the different approaches, these data strongly suggest 
that Salmonella effector protein SifB specifically targets the host microtubule-binding protein 
CLIP4. 
Together, this study identifies new interaction partners of SifA and SifB and paves the way to 
a deeper understanding of the late steps of Salmonella infection. 
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I List of abbreviations 
A  Ampere 
aa amino acid(s) 
amp Ampicillin 
ANK ankyrin repeat 
ApE a plasmid editor 
APPL1 adaptor protein, phosphotyrosine interacting with PH domain and leucine 
zipper 1 
APS ammonium persulfate 
BICD2 bicaudal D homolog 2 
BLAST  basic local alignment search tool 
bp Base pair 
BSA  bovine serum albumin 
cDNA complementary DNA 
°C degree Celsius 
Cep70 centrosomal protein 70 
CLIP4 CAP-Gly Domain Containing Linker Protein Family Member 4 
CRISPR Clustered regularly interspaced short palindromic repeats 
CS centriolar satellites  
C-terminus  carboxy-terminus 
CYLD cylindromatosis (turban tumor syndrome) 
∆ delta 
Ø diameter 
DAPI 4',6-diamidino-2-phenylindole 
DDB dynein-dynactin-BICD2N 
DKFZ German Cancer Research Center 
DNA  deoxyribonucleic acid 
dNTP  deoxynucleotide-triphosphate 
DMEM Dulbeccos' modified Eagle medium 
DMSO dimethyl sulfoxide 
DYNLRB1 Dynein Light Chain Roadblock type-1 protein  
 EB end-binding proteins 
E. coli Escherichia coli 
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ECDC European Centre for Disease Prevention and Control 
EDTA ethylenediaminetetraacetic acid 
EEA European Economic Area 
EEA1 early endosomal antigen 1 
e.g. exempli gratia 
EHEC enterohemorrhagic E.coli 
EPEC enteropathogenic E.coli 
E/P glutamate-proline rich 
ER  endoplasmic reticulum 
ELISA  enzyme-linked immunosorbent assay 
et al. et alii 
EU European Union 
FACS  fluorescence-activated cell sorting 
FCS fetal calf serum 
FL full-length 
For forward 
g gram 
GAP GTPase activating protein 
GDI guanosine nucleotide dissociation inhibitors 
GDP guanosine diphosphate 
GEO Gene Expression Omnibus 
GFP  green fluorescent protein 
GEF guanosine nucleotide exchange factor 
GTP guanosine triphosphate 
h hour(s) 
HDAC6 histone deacetylase 6 
HEK  human embryonic kidney 
HRP  horseradish peroxidase 
HZI  Helmholtz Centre for Infection Research 
IF immunofluorescence microscopy 
IM inner membrane 
IPTG isopropyl β-D-1-thiogalactopyranosid 
kana kanamycin 
kDa  kilodalton 
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KO knockout 
l liter(s) 
LAMPs lysosome-associated membrane proteins  
LB Luria Bertani broth 
LC3 microtubule-associated protein 1 light chain 3 
LE late endosome markers  
LNTs LAMP1-negative tubules 
Lys lysosome markers 
µ micro- 
m milli- or meter(s) 
M  molar 
MBP maltose binding protein 
mc monoclonal 
MHH Medizinischen Hochschule Hannover 
min minute(s) 
mRNA  messenger RNA 
Mm Mus musculus 
MS membrane and supramembrane 
MTOC microtubule-organizing centre 
MTs microtubules 
n nano- 
NAGK N-acetylglucosamine kinase 
NCBI  National Center for Biotechnology Information 
N-terminus  amino-terminus 
NTS non-typhoidal Salmonella 
OD600 optical density at 600 nm 
OM outer membrane 
OPTN optineurin 
PAGE  polyacrylamide gel electrophoresis 
PBS  phosphate-buffered saline 
PCR  polymerase chain reaction 
pc polyclonal 
PFA paraformaldehyde 
PH pleckstrin homology  
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Pi phosphate 
p.i. post invasion 
% percent 
PCM1 pericentriolar material 1 protein  
PLEKHM1 pleckstrin homology domain-containing protein family member 1 
® registered trademark symbol 
RASSF1A Ras association domain family 1A  
RILP Rab-interacting lysosomal protein  
PMT palmitoylation membrane-targeting motif 
P/S penicillin/streptomycin 
PVDF polyvinylidenfluorid 
RFP red fluorescent protein 
Rev reverse 
RNAi  RNA interference 
rpm rounds per minute 
RT room temperature 
s second(s) 
SCV Salmonella containing vacuole 
Sct secretion and cellular translocation 
SDS sodium dodecyl sulfate 
sgRNA single guide RNA 
SIFs Salmonella induced filaments 
SISTs Salmonella-induced secretory carrier membrane protein 3 (SCAMP3) tubules  
SKIP SifA and kinesin-interacting protein 
SLRs sequestosome 1/p62-like receptors  
SNX sorting nexin tubules  
SPI Salmonella pathogenicity island 
Sip  Salmonella invasion protein 
Sop  Salmonella outer protein 
t time 
TAE tris base, acetic acid and EDTA containing buffer 
TBS  tris-buffered saline 
TBS/T  tris-buffered saline / Tween 20 
TEMED N, N, N, N,-Tetramethylethylenediamine 
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TGN trans-Golgi network 
T3SS type 3 secretion system 
TIF tagged image file format 
+TIPs microtubule plus-end tracking proteins 
™ trademarkt 
TU  Technical University 
U unit 
UV  ultraviolet 
V  volt 
vATPase vacuolar ATPase 
VHL-Sp von-Hippl-Lindau-Syndrome-protein 
v/v volume per volume 
WHO world health organization 
w/v weight per volume 
WT  wild type 
x times magnification 
xg times gravitation constant 
Y2H yeast two hybrid 
ZnF zinc finger domain 
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IV Supplementary data 
 
Figure 50: CLIP4-FL and CLIP4-∆ANK stabilize microtubules upon treatment with microtubule-depolymerizing 
drug nocodazole.Cos-7 cells were transfected with respective GFP-tagged constructs of CLIP4, 24 hours later cells were 
treated with nocodazole and fixed with PFA and permeabilized. Nuclei were stained with DAPI (blue). (A) Staining of cells 
with anti-α-tubulin antibody revealed that CLIP4-FL and CLIP4-∆ANK stabilize microtubules in the presence of nocodazole. 
(B) Staining of cells with anti-acetylated tubulin antibody revealed that CLIP4-FL and CLIP4-∆ANK protect mainly 
acetylated microtubules from nocodazole. Merge shows an overlay of the green, red and blue channel. Yellow and red arrows 
highlight transfected GFP-CLIP4-FL or GFP-CLIP4-∆ANK and untransfected cells, respectively. 
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